PRJNA375882: Comprehensive Mouse Transcriptomic BodyMap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Maz
|
ENSMUSG00000030678.8 | Maz |
Zfp281
|
ENSMUSG00000041483.15 | Zfp281 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Zfp281 | mm39_v1_chr1_+_136552639_136552688 | 0.60 | 2.9e-08 | Click! |
Maz | mm39_v1_chr7_-_126625739_126625780 | 0.58 | 8.9e-08 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr10_+_126914755 | 14.23 |
ENSMUST00000039259.7
ENSMUST00000217941.2 |
Agap2
|
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 |
chr11_+_69909245 | 13.74 |
ENSMUST00000231415.2
ENSMUST00000108588.9 |
Dlg4
|
discs large MAGUK scaffold protein 4 |
chr15_-_89033761 | 13.53 |
ENSMUST00000088823.5
|
Mapk11
|
mitogen-activated protein kinase 11 |
chrX_-_134111421 | 13.12 |
ENSMUST00000033783.2
|
Tceal6
|
transcription elongation factor A (SII)-like 6 |
chr9_+_43954681 | 11.91 |
ENSMUST00000114840.2
|
Thy1
|
thymus cell antigen 1, theta |
chr7_-_105230395 | 11.61 |
ENSMUST00000188726.2
ENSMUST00000188440.7 |
Apbb1
|
amyloid beta (A4) precursor protein-binding, family B, member 1 |
chr2_-_180798785 | 11.34 |
ENSMUST00000055990.8
|
Eef1a2
|
eukaryotic translation elongation factor 1 alpha 2 |
chr7_-_105230479 | 10.85 |
ENSMUST00000191601.7
|
Apbb1
|
amyloid beta (A4) precursor protein-binding, family B, member 1 |
chrX_+_135567124 | 10.21 |
ENSMUST00000060904.11
ENSMUST00000113100.2 ENSMUST00000128040.2 |
Tceal3
|
transcription elongation factor A (SII)-like 3 |
chr8_+_96404713 | 9.88 |
ENSMUST00000041318.14
|
Ndrg4
|
N-myc downstream regulated gene 4 |
chr17_+_27160356 | 9.84 |
ENSMUST00000229490.2
ENSMUST00000201702.5 ENSMUST00000177932.7 ENSMUST00000201349.6 |
Syngap1
|
synaptic Ras GTPase activating protein 1 homolog (rat) |
chr2_-_180596469 | 9.74 |
ENSMUST00000148905.8
ENSMUST00000103053.10 ENSMUST00000108873.9 |
Nkain4
|
Na+/K+ transporting ATPase interacting 4 |
chr11_+_69909659 | 9.72 |
ENSMUST00000232002.2
ENSMUST00000134376.10 ENSMUST00000231221.2 |
Dlg4
|
discs large MAGUK scaffold protein 4 |
chr15_-_25413838 | 9.46 |
ENSMUST00000058845.9
|
Basp1
|
brain abundant, membrane attached signal protein 1 |
chr7_+_44091822 | 9.46 |
ENSMUST00000058667.15
|
Lrrc4b
|
leucine rich repeat containing 4B |
chrX_+_52609954 | 9.11 |
ENSMUST00000063384.4
|
Rtl8c
|
retrotransposon Gag like 8C |
chr10_+_70276604 | 9.08 |
ENSMUST00000173042.9
ENSMUST00000062883.7 |
Fam13c
|
family with sequence similarity 13, member C |
chr6_-_124840824 | 9.06 |
ENSMUST00000046893.10
ENSMUST00000204667.2 |
Gpr162
|
G protein-coupled receptor 162 |
chr3_+_96088467 | 8.97 |
ENSMUST00000035371.9
|
Sv2a
|
synaptic vesicle glycoprotein 2 a |
chr7_-_24771717 | 8.96 |
ENSMUST00000003468.10
|
Grik5
|
glutamate receptor, ionotropic, kainate 5 (gamma 2) |
chr7_+_43959637 | 8.89 |
ENSMUST00000107938.8
|
Shank1
|
SH3 and multiple ankyrin repeat domains 1 |
chr4_-_129015493 | 8.88 |
ENSMUST00000135763.2
ENSMUST00000149763.3 ENSMUST00000164649.8 |
Hpca
|
hippocalcin |
chr5_+_107551362 | 8.82 |
ENSMUST00000049146.12
|
Ephx4
|
epoxide hydrolase 4 |
chr8_+_94537460 | 8.69 |
ENSMUST00000034198.15
ENSMUST00000125716.8 |
Gnao1
|
guanine nucleotide binding protein, alpha O |
chr15_-_99425555 | 8.67 |
ENSMUST00000231171.2
|
Faim2
|
Fas apoptotic inhibitory molecule 2 |
chr2_+_92430043 | 8.64 |
ENSMUST00000065797.7
|
Chst1
|
carbohydrate sulfotransferase 1 |
chr7_-_28868072 | 8.60 |
ENSMUST00000048923.7
|
Spred3
|
sprouty-related EVH1 domain containing 3 |
chr7_+_19024994 | 8.49 |
ENSMUST00000108468.5
|
Rtn2
|
reticulon 2 (Z-band associated protein) |
chr7_+_3381434 | 8.34 |
ENSMUST00000092891.6
|
Cacng7
|
calcium channel, voltage-dependent, gamma subunit 7 |
chr7_+_45349267 | 8.33 |
ENSMUST00000003360.10
|
Car11
|
carbonic anhydrase 11 |
chr5_+_122239007 | 8.29 |
ENSMUST00000014080.13
ENSMUST00000111750.8 |
Myl2
|
myosin, light polypeptide 2, regulatory, cardiac, slow |
chr11_-_97913420 | 8.28 |
ENSMUST00000103144.10
ENSMUST00000017552.13 ENSMUST00000092736.11 ENSMUST00000107562.2 |
Cacnb1
|
calcium channel, voltage-dependent, beta 1 subunit |
chr3_+_156267429 | 8.26 |
ENSMUST00000074015.11
|
Negr1
|
neuronal growth regulator 1 |
chr7_-_127423641 | 8.25 |
ENSMUST00000106267.5
|
Stx1b
|
syntaxin 1B |
chr3_+_105611915 | 8.07 |
ENSMUST00000066610.8
|
Inka2
|
inka box actin regulator 2 |
chr7_+_126422458 | 8.04 |
ENSMUST00000079423.7
|
Tlcd3b
|
TLC domain containing 3B |
chr11_-_120622770 | 7.99 |
ENSMUST00000154565.2
ENSMUST00000026148.9 |
Cbr2
|
carbonyl reductase 2 |
chr3_-_89152320 | 7.92 |
ENSMUST00000107464.8
ENSMUST00000090924.13 |
Trim46
|
tripartite motif-containing 46 |
chr1_+_134110142 | 7.92 |
ENSMUST00000082060.10
ENSMUST00000153856.8 ENSMUST00000133701.8 ENSMUST00000132873.8 |
Chil1
|
chitinase-like 1 |
chr8_+_72021510 | 7.87 |
ENSMUST00000212889.2
|
Slc27a1
|
solute carrier family 27 (fatty acid transporter), member 1 |
chr13_+_42862957 | 7.82 |
ENSMUST00000066928.12
ENSMUST00000148891.8 |
Phactr1
|
phosphatase and actin regulator 1 |
chr9_+_59564482 | 7.79 |
ENSMUST00000216620.2
ENSMUST00000217038.2 |
Pkm
|
pyruvate kinase, muscle |
chr5_+_37025810 | 7.75 |
ENSMUST00000031003.11
|
Ppp2r2c
|
protein phosphatase 2, regulatory subunit B, gamma |
chr19_-_5560473 | 7.71 |
ENSMUST00000237111.2
ENSMUST00000070172.6 |
Snx32
|
sorting nexin 32 |
chr7_-_142211203 | 7.64 |
ENSMUST00000097936.9
ENSMUST00000000033.12 |
Igf2
|
insulin-like growth factor 2 |
chr7_-_24705320 | 7.63 |
ENSMUST00000102858.10
ENSMUST00000196684.2 ENSMUST00000080882.11 |
Atp1a3
|
ATPase, Na+/K+ transporting, alpha 3 polypeptide |
chr17_-_57394718 | 7.61 |
ENSMUST00000071135.6
|
Tubb4a
|
tubulin, beta 4A class IVA |
chr3_+_55369288 | 7.61 |
ENSMUST00000198412.5
ENSMUST00000199169.5 ENSMUST00000199702.5 ENSMUST00000198437.5 |
Dclk1
|
doublecortin-like kinase 1 |
chr7_-_30614249 | 7.59 |
ENSMUST00000190950.7
ENSMUST00000187137.7 ENSMUST00000190638.7 |
Mag
|
myelin-associated glycoprotein |
chr3_+_55369149 | 7.58 |
ENSMUST00000199585.5
ENSMUST00000070418.9 |
Dclk1
|
doublecortin-like kinase 1 |
chrX_-_135116192 | 7.57 |
ENSMUST00000113120.2
ENSMUST00000113118.2 ENSMUST00000058125.9 |
Bex1
|
brain expressed X-linked 1 |
chr13_+_46655324 | 7.55 |
ENSMUST00000021802.16
|
Cap2
|
CAP, adenylate cyclase-associated protein, 2 (yeast) |
chr9_-_86762467 | 7.50 |
ENSMUST00000074501.12
ENSMUST00000239074.2 ENSMUST00000098495.10 ENSMUST00000036347.13 ENSMUST00000074468.13 |
Snap91
|
synaptosomal-associated protein 91 |
chrX_-_36253309 | 7.50 |
ENSMUST00000060474.14
ENSMUST00000053456.11 ENSMUST00000115239.10 |
Septin6
|
septin 6 |
chrX_+_135608725 | 7.50 |
ENSMUST00000055104.6
|
Tceal1
|
transcription elongation factor A (SII)-like 1 |
chrX_-_72703330 | 7.50 |
ENSMUST00000114473.8
ENSMUST00000002087.14 |
Pnck
|
pregnancy upregulated non-ubiquitously expressed CaM kinase |
chr4_-_129015682 | 7.44 |
ENSMUST00000139450.8
ENSMUST00000125931.9 ENSMUST00000116444.10 |
Hpca
|
hippocalcin |
chr17_+_27160203 | 7.42 |
ENSMUST00000194598.6
|
Syngap1
|
synaptic Ras GTPase activating protein 1 homolog (rat) |
chr5_+_122239030 | 7.38 |
ENSMUST00000139213.8
ENSMUST00000111751.8 ENSMUST00000155612.8 |
Myl2
|
myosin, light polypeptide 2, regulatory, cardiac, slow |
chr2_-_180956293 | 7.33 |
ENSMUST00000103045.4
|
Stmn3
|
stathmin-like 3 |
chr7_+_29991101 | 7.25 |
ENSMUST00000150892.2
ENSMUST00000126216.2 ENSMUST00000014065.16 |
Clip3
|
CAP-GLY domain containing linker protein 3 |
chr1_+_12762501 | 7.24 |
ENSMUST00000177608.8
ENSMUST00000180062.8 |
Sulf1
|
sulfatase 1 |
chrX_+_165127688 | 7.20 |
ENSMUST00000112223.8
ENSMUST00000112224.8 ENSMUST00000112229.9 ENSMUST00000112228.8 ENSMUST00000112227.9 ENSMUST00000112226.3 |
Gpm6b
|
glycoprotein m6b |
chr9_-_37058590 | 7.16 |
ENSMUST00000080754.12
ENSMUST00000188057.7 ENSMUST00000039674.13 |
Pknox2
|
Pbx/knotted 1 homeobox 2 |
chr10_-_67748461 | 7.10 |
ENSMUST00000064656.8
|
Zfp365
|
zinc finger protein 365 |
chr13_+_46655617 | 7.05 |
ENSMUST00000225824.2
|
Cap2
|
CAP, adenylate cyclase-associated protein, 2 (yeast) |
chr15_+_83676140 | 6.99 |
ENSMUST00000172115.8
ENSMUST00000172398.2 |
Mpped1
|
metallophosphoesterase domain containing 1 |
chr1_+_75522902 | 6.99 |
ENSMUST00000124341.8
|
Slc4a3
|
solute carrier family 4 (anion exchanger), member 3 |
chr1_+_34840785 | 6.97 |
ENSMUST00000047664.16
ENSMUST00000211073.2 |
Arhgef4
SMIM39
|
Rho guanine nucleotide exchange factor (GEF) 4 novel protein |
chr7_-_105230698 | 6.94 |
ENSMUST00000189378.7
|
Apbb1
|
amyloid beta (A4) precursor protein-binding, family B, member 1 |
chr19_+_5348329 | 6.89 |
ENSMUST00000061169.7
|
Gal3st3
|
galactose-3-O-sulfotransferase 3 |
chr7_+_15909283 | 6.88 |
ENSMUST00000002495.18
|
Meis3
|
Meis homeobox 3 |
chr2_-_17735847 | 6.86 |
ENSMUST00000028080.12
|
Nebl
|
nebulette |
chr12_+_81678143 | 6.85 |
ENSMUST00000036116.6
|
Ttc9
|
tetratricopeptide repeat domain 9 |
chr17_+_34848507 | 6.82 |
ENSMUST00000015620.7
|
Prrt1
|
proline-rich transmembrane protein 1 |
chr1_+_92759324 | 6.78 |
ENSMUST00000045970.8
|
Gpc1
|
glypican 1 |
chr7_+_3439144 | 6.75 |
ENSMUST00000182222.8
|
Cacng8
|
calcium channel, voltage-dependent, gamma subunit 8 |
chr10_-_76459152 | 6.70 |
ENSMUST00000105413.8
|
Col6a2
|
collagen, type VI, alpha 2 |
chr12_+_12312163 | 6.67 |
ENSMUST00000069005.10
ENSMUST00000223061.2 |
Cyria
|
CYFIP related Rac1 interactor A |
chr14_-_29443792 | 6.64 |
ENSMUST00000022567.9
|
Cacna2d3
|
calcium channel, voltage-dependent, alpha2/delta subunit 3 |
chr9_+_43957241 | 6.64 |
ENSMUST00000214627.2
|
Thy1
|
thymus cell antigen 1, theta |
chr7_-_45750153 | 6.63 |
ENSMUST00000180081.3
|
Kcnj11
|
potassium inwardly rectifying channel, subfamily J, member 11 |
chr15_+_98006346 | 6.62 |
ENSMUST00000051226.8
|
Pfkm
|
phosphofructokinase, muscle |
chr7_-_126620378 | 6.62 |
ENSMUST00000159916.5
|
Prrt2
|
proline-rich transmembrane protein 2 |
chr6_+_29396574 | 6.60 |
ENSMUST00000115275.8
ENSMUST00000145310.8 ENSMUST00000096084.12 |
Ccdc136
|
coiled-coil domain containing 136 |
chr8_-_70939964 | 6.57 |
ENSMUST00000045286.9
|
Tmem59l
|
transmembrane protein 59-like |
chr13_-_99653045 | 6.56 |
ENSMUST00000064762.6
|
Map1b
|
microtubule-associated protein 1B |
chr9_-_20657643 | 6.55 |
ENSMUST00000215999.2
|
Olfm2
|
olfactomedin 2 |
chr13_+_46655589 | 6.55 |
ENSMUST00000119341.2
|
Cap2
|
CAP, adenylate cyclase-associated protein, 2 (yeast) |
chr11_+_83300481 | 6.52 |
ENSMUST00000175848.8
ENSMUST00000108140.10 |
Rasl10b
|
RAS-like, family 10, member B |
chr7_-_4518958 | 6.52 |
ENSMUST00000163710.8
ENSMUST00000166268.8 ENSMUST00000071798.13 ENSMUST00000178163.8 ENSMUST00000108587.9 |
Tnnt1
|
troponin T1, skeletal, slow |
chr6_+_118043307 | 6.51 |
ENSMUST00000203804.3
ENSMUST00000203482.2 |
Rasgef1a
|
RasGEF domain family, member 1A |
chr17_+_35454833 | 6.48 |
ENSMUST00000118384.8
|
Atp6v1g2
|
ATPase, H+ transporting, lysosomal V1 subunit G2 |
chr10_-_127024641 | 6.48 |
ENSMUST00000218654.2
|
Arhgef25
|
Rho guanine nucleotide exchange factor (GEF) 25 |
chr7_+_34885782 | 6.45 |
ENSMUST00000135452.8
ENSMUST00000001854.12 |
Slc7a10
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 10 |
chr11_+_94881861 | 6.45 |
ENSMUST00000038696.12
|
Ppp1r9b
|
protein phosphatase 1, regulatory subunit 9B |
chr11_-_69728560 | 6.44 |
ENSMUST00000108634.9
|
Nlgn2
|
neuroligin 2 |
chr8_+_72021567 | 6.44 |
ENSMUST00000034267.5
|
Slc27a1
|
solute carrier family 27 (fatty acid transporter), member 1 |
chr7_+_18915086 | 6.44 |
ENSMUST00000120595.8
ENSMUST00000048502.10 |
Eml2
|
echinoderm microtubule associated protein like 2 |
chr8_+_73325912 | 6.43 |
ENSMUST00000034244.9
|
Tmem38a
|
transmembrane protein 38A |
chr10_+_59942020 | 6.39 |
ENSMUST00000121820.9
|
Spock2
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan 2 |
chr15_+_97990431 | 6.37 |
ENSMUST00000229280.2
ENSMUST00000163507.8 ENSMUST00000230445.2 |
Pfkm
|
phosphofructokinase, muscle |
chr8_+_73325871 | 6.36 |
ENSMUST00000212763.2
|
Tmem38a
|
transmembrane protein 38A |
chr9_+_51676625 | 6.34 |
ENSMUST00000065496.12
|
Arhgap20
|
Rho GTPase activating protein 20 |
chr12_+_81678002 | 6.33 |
ENSMUST00000218362.2
|
Ttc9
|
tetratricopeptide repeat domain 9 |
chr4_+_130202388 | 6.33 |
ENSMUST00000070532.8
|
Fabp3
|
fatty acid binding protein 3, muscle and heart |
chr10_-_76562002 | 6.31 |
ENSMUST00000001147.5
|
Col6a1
|
collagen, type VI, alpha 1 |
chr7_+_30450896 | 6.26 |
ENSMUST00000182229.8
ENSMUST00000080518.14 ENSMUST00000182227.8 ENSMUST00000182721.8 |
Sbsn
|
suprabasin |
chr1_-_177085736 | 6.24 |
ENSMUST00000111159.2
|
Akt3
|
thymoma viral proto-oncogene 3 |
chr18_+_38088597 | 6.24 |
ENSMUST00000070709.9
ENSMUST00000177058.8 ENSMUST00000169360.9 ENSMUST00000163591.9 ENSMUST00000091932.12 |
Rell2
|
RELT-like 2 |
chr2_-_180596413 | 6.24 |
ENSMUST00000139929.8
|
Nkain4
|
Na+/K+ transporting ATPase interacting 4 |
chr2_+_55327110 | 6.23 |
ENSMUST00000112633.3
ENSMUST00000112632.2 |
Kcnj3
|
potassium inwardly-rectifying channel, subfamily J, member 3 |
chr10_+_56255184 | 6.20 |
ENSMUST00000220069.2
|
Gja1
|
gap junction protein, alpha 1 |
chr1_-_172125555 | 6.18 |
ENSMUST00000085913.11
ENSMUST00000097464.4 |
Atp1a2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
chr9_+_102988940 | 6.17 |
ENSMUST00000189134.2
ENSMUST00000035155.8 |
Rab6b
|
RAB6B, member RAS oncogene family |
chr11_+_69917640 | 6.17 |
ENSMUST00000135916.9
ENSMUST00000232659.2 |
Dlg4
|
discs large MAGUK scaffold protein 4 |
chr11_+_56902658 | 6.15 |
ENSMUST00000094179.11
|
Gria1
|
glutamate receptor, ionotropic, AMPA1 (alpha 1) |
chr18_+_59195534 | 6.15 |
ENSMUST00000058633.9
ENSMUST00000175897.8 ENSMUST00000118510.8 ENSMUST00000175830.2 |
Minar2
|
membrane integral NOTCH2 associated receptor 2 |
chr2_+_14828903 | 6.13 |
ENSMUST00000193800.6
|
Cacnb2
|
calcium channel, voltage-dependent, beta 2 subunit |
chr11_+_56902624 | 6.13 |
ENSMUST00000036315.16
|
Gria1
|
glutamate receptor, ionotropic, AMPA1 (alpha 1) |
chr2_-_131871725 | 6.12 |
ENSMUST00000028814.15
|
Rassf2
|
Ras association (RalGDS/AF-6) domain family member 2 |
chr4_-_148244028 | 6.12 |
ENSMUST00000167160.8
ENSMUST00000151246.8 |
Fbxo44
|
F-box protein 44 |
chr1_-_93029547 | 6.11 |
ENSMUST00000112958.9
ENSMUST00000186861.2 ENSMUST00000171556.8 |
Kif1a
|
kinesin family member 1A |
chrX_+_134739783 | 6.06 |
ENSMUST00000173804.8
ENSMUST00000113136.8 |
Gprasp2
|
G protein-coupled receptor associated sorting protein 2 |
chr17_+_5991555 | 6.04 |
ENSMUST00000115791.10
ENSMUST00000080283.13 |
Synj2
|
synaptojanin 2 |
chr8_+_57908920 | 6.00 |
ENSMUST00000034023.4
|
Scrg1
|
scrapie responsive gene 1 |
chr11_-_101917745 | 5.99 |
ENSMUST00000107167.2
ENSMUST00000062801.11 |
Mpp3
|
membrane protein, palmitoylated 3 (MAGUK p55 subfamily member 3) |
chr7_+_15909200 | 5.93 |
ENSMUST00000176506.8
|
Meis3
|
Meis homeobox 3 |
chr1_-_93029532 | 5.93 |
ENSMUST00000171796.8
|
Kif1a
|
kinesin family member 1A |
chr12_-_72455708 | 5.89 |
ENSMUST00000078505.14
|
Rtn1
|
reticulon 1 |
chrX_-_94209913 | 5.85 |
ENSMUST00000113873.9
ENSMUST00000113876.9 ENSMUST00000199920.5 ENSMUST00000113885.8 ENSMUST00000113883.8 ENSMUST00000196012.2 ENSMUST00000182001.8 ENSMUST00000113878.8 ENSMUST00000113882.8 ENSMUST00000182562.2 |
Arhgef9
|
CDC42 guanine nucleotide exchange factor (GEF) 9 |
chr1_+_75483721 | 5.84 |
ENSMUST00000037330.5
|
Inha
|
inhibin alpha |
chr15_+_102052797 | 5.80 |
ENSMUST00000023807.7
|
Igfbp6
|
insulin-like growth factor binding protein 6 |
chr11_-_69451012 | 5.76 |
ENSMUST00000004036.6
|
Efnb3
|
ephrin B3 |
chr10_-_127031578 | 5.76 |
ENSMUST00000038217.14
ENSMUST00000130855.8 ENSMUST00000116229.2 ENSMUST00000144322.8 |
Dtx3
|
deltex 3, E3 ubiquitin ligase |
chr2_+_31985528 | 5.73 |
ENSMUST00000057423.6
ENSMUST00000140762.2 |
Plpp7
|
phospholipid phosphatase 7 (inactive) |
chr7_+_15863679 | 5.72 |
ENSMUST00000211649.2
|
Slc8a2
|
solute carrier family 8 (sodium/calcium exchanger), member 2 |
chr19_+_5790918 | 5.70 |
ENSMUST00000081496.6
|
Ltbp3
|
latent transforming growth factor beta binding protein 3 |
chr10_-_8394546 | 5.67 |
ENSMUST00000061601.9
|
Ust
|
uronyl-2-sulfotransferase |
chr5_+_43829631 | 5.65 |
ENSMUST00000125866.4
|
Cc2d2a
|
coiled-coil and C2 domain containing 2A |
chr13_-_105191403 | 5.64 |
ENSMUST00000063551.7
|
Rgs7bp
|
regulator of G-protein signalling 7 binding protein |
chr2_-_115896279 | 5.64 |
ENSMUST00000110907.8
ENSMUST00000110908.9 |
Meis2
|
Meis homeobox 2 |
chr11_+_97732108 | 5.63 |
ENSMUST00000155954.3
ENSMUST00000164364.2 ENSMUST00000170806.2 |
B230217C12Rik
|
RIKEN cDNA B230217C12 gene |
chr5_+_16139760 | 5.62 |
ENSMUST00000101581.10
ENSMUST00000039370.14 ENSMUST00000199704.5 ENSMUST00000180204.8 ENSMUST00000078272.13 ENSMUST00000115281.7 |
Cacna2d1
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
chr3_-_126792056 | 5.60 |
ENSMUST00000044443.15
|
Ank2
|
ankyrin 2, brain |
chr14_-_55150547 | 5.57 |
ENSMUST00000228495.3
ENSMUST00000228119.3 ENSMUST00000050772.10 ENSMUST00000231305.2 |
Slc22a17
|
solute carrier family 22 (organic cation transporter), member 17 |
chr11_-_97877219 | 5.56 |
ENSMUST00000107565.3
ENSMUST00000107564.2 ENSMUST00000017561.15 |
Plxdc1
|
plexin domain containing 1 |
chr1_-_168259839 | 5.56 |
ENSMUST00000188912.7
|
Pbx1
|
pre B cell leukemia homeobox 1 |
chrX_-_71699740 | 5.55 |
ENSMUST00000055966.13
|
Gabra3
|
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 3 |
chr4_-_148244299 | 5.52 |
ENSMUST00000151127.8
ENSMUST00000105705.9 |
Fbxo44
|
F-box protein 44 |
chr1_-_191050283 | 5.51 |
ENSMUST00000046770.10
|
Nenf
|
neuron derived neurotrophic factor |
chr7_+_15864265 | 5.50 |
ENSMUST00000168693.3
|
Slc8a2
|
solute carrier family 8 (sodium/calcium exchanger), member 2 |
chr7_+_40547608 | 5.49 |
ENSMUST00000044705.12
|
Vstm2b
|
V-set and transmembrane domain containing 2B |
chr11_-_61344818 | 5.49 |
ENSMUST00000060255.14
ENSMUST00000054927.14 ENSMUST00000102661.4 |
Rnf112
|
ring finger protein 112 |
chr4_+_97665992 | 5.47 |
ENSMUST00000107062.9
ENSMUST00000052018.12 ENSMUST00000107057.8 |
Nfia
|
nuclear factor I/A |
chr9_+_21108001 | 5.45 |
ENSMUST00000003395.10
|
Pde4a
|
phosphodiesterase 4A, cAMP specific |
chr15_-_75438457 | 5.42 |
ENSMUST00000163116.8
ENSMUST00000023241.12 |
Ly6h
|
lymphocyte antigen 6 complex, locus H |
chr16_+_84571011 | 5.42 |
ENSMUST00000114195.8
|
Jam2
|
junction adhesion molecule 2 |
chr9_+_43956969 | 5.42 |
ENSMUST00000215809.2
|
Thy1
|
thymus cell antigen 1, theta |
chr9_+_45029080 | 5.38 |
ENSMUST00000170998.9
ENSMUST00000093855.4 |
Scn2b
|
sodium channel, voltage-gated, type II, beta |
chr14_+_47120311 | 5.37 |
ENSMUST00000022386.15
ENSMUST00000228404.2 ENSMUST00000100672.11 |
Samd4
|
sterile alpha motif domain containing 4 |
chr18_+_59195354 | 5.37 |
ENSMUST00000165666.9
|
Minar2
|
membrane integral NOTCH2 associated receptor 2 |
chr8_+_94879235 | 5.36 |
ENSMUST00000034211.10
ENSMUST00000211930.2 ENSMUST00000211915.2 |
Mt3
|
metallothionein 3 |
chr3_+_28317570 | 5.35 |
ENSMUST00000160307.9
ENSMUST00000159680.9 ENSMUST00000160518.8 ENSMUST00000162485.8 ENSMUST00000159308.8 ENSMUST00000162777.8 ENSMUST00000161964.2 |
Tnik
|
TRAF2 and NCK interacting kinase |
chr6_-_115229128 | 5.35 |
ENSMUST00000032462.9
|
Timp4
|
tissue inhibitor of metalloproteinase 4 |
chr2_+_125514997 | 5.34 |
ENSMUST00000164756.4
|
Eid1
|
EP300 interacting inhibitor of differentiation 1 |
chr6_-_114018982 | 5.28 |
ENSMUST00000101045.10
|
Atp2b2
|
ATPase, Ca++ transporting, plasma membrane 2 |
chr11_+_17001818 | 5.24 |
ENSMUST00000058159.6
|
Cnrip1
|
cannabinoid receptor interacting protein 1 |
chr11_-_119937970 | 5.23 |
ENSMUST00000103020.8
|
Aatk
|
apoptosis-associated tyrosine kinase |
chrX_-_58179754 | 5.23 |
ENSMUST00000033473.12
|
Fgf13
|
fibroblast growth factor 13 |
chr8_+_84626715 | 5.22 |
ENSMUST00000141158.8
|
Adgrl1
|
adhesion G protein-coupled receptor L1 |
chr16_-_42160957 | 5.21 |
ENSMUST00000102817.5
|
Gap43
|
growth associated protein 43 |
chr7_+_3352019 | 5.21 |
ENSMUST00000100301.11
|
Prkcg
|
protein kinase C, gamma |
chr10_-_127025851 | 5.20 |
ENSMUST00000222006.2
ENSMUST00000019611.15 ENSMUST00000219245.2 |
Arhgef25
|
Rho guanine nucleotide exchange factor (GEF) 25 |
chr9_-_108474757 | 5.18 |
ENSMUST00000193621.2
ENSMUST00000006853.11 |
P4htm
|
prolyl 4-hydroxylase, transmembrane (endoplasmic reticulum) |
chr11_+_98632953 | 5.18 |
ENSMUST00000153043.8
|
Thra
|
thyroid hormone receptor alpha |
chr12_+_44375665 | 5.16 |
ENSMUST00000110748.4
|
Nrcam
|
neuronal cell adhesion molecule |
chr10_+_70276473 | 5.16 |
ENSMUST00000105436.9
|
Fam13c
|
family with sequence similarity 13, member C |
chr17_-_26420300 | 5.16 |
ENSMUST00000025019.9
|
Arhgdig
|
Rho GDP dissociation inhibitor (GDI) gamma |
chr11_+_42310557 | 5.14 |
ENSMUST00000007797.10
|
Gabrb2
|
gamma-aminobutyric acid (GABA) A receptor, subunit beta 2 |
chr12_+_12312135 | 5.14 |
ENSMUST00000069066.14
|
Cyria
|
CYFIP related Rac1 interactor A |
chr1_-_134260666 | 5.13 |
ENSMUST00000168515.8
ENSMUST00000189361.2 |
Ppfia4
|
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 4 |
chr7_-_139734637 | 5.12 |
ENSMUST00000059241.8
|
Sprn
|
shadow of prion protein |
chr12_+_44375747 | 5.11 |
ENSMUST00000020939.16
ENSMUST00000220126.2 |
Nrcam
|
neuronal cell adhesion molecule |
chr4_-_148244489 | 5.10 |
ENSMUST00000057907.10
|
Fbxo44
|
F-box protein 44 |
chr7_+_44078366 | 5.09 |
ENSMUST00000127790.8
|
Lrrc4b
|
leucine rich repeat containing 4B |
chr7_-_126620249 | 5.06 |
ENSMUST00000202045.2
|
Prrt2
|
proline-rich transmembrane protein 2 |
chr5_-_24534554 | 5.05 |
ENSMUST00000115098.7
|
Kcnh2
|
potassium voltage-gated channel, subfamily H (eag-related), member 2 |
chr4_+_129878890 | 5.05 |
ENSMUST00000106017.8
ENSMUST00000121049.8 |
Adgrb2
|
adhesion G protein-coupled receptor B2 |
chr9_-_37464200 | 5.04 |
ENSMUST00000065668.12
|
Nrgn
|
neurogranin |
chr1_+_20960819 | 5.04 |
ENSMUST00000189400.7
|
Paqr8
|
progestin and adipoQ receptor family member VIII |
chr1_-_75240551 | 5.01 |
ENSMUST00000186178.7
ENSMUST00000189769.7 ENSMUST00000027404.12 |
Ptprn
|
protein tyrosine phosphatase, receptor type, N |
chr1_-_135302971 | 5.00 |
ENSMUST00000041240.4
|
Shisa4
|
shisa family member 4 |
chr10_+_59942274 | 5.00 |
ENSMUST00000165024.3
|
Spock2
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan 2 |
chr6_-_60805873 | 4.99 |
ENSMUST00000114268.5
|
Snca
|
synuclein, alpha |
chr2_+_90716204 | 4.96 |
ENSMUST00000111466.3
|
C1qtnf4
|
C1q and tumor necrosis factor related protein 4 |
chr11_+_54195006 | 4.95 |
ENSMUST00000108904.10
ENSMUST00000108905.10 |
Acsl6
|
acyl-CoA synthetase long-chain family member 6 |
chr6_+_127864543 | 4.92 |
ENSMUST00000032501.6
|
Tspan11
|
tetraspanin 11 |
chr14_+_76714350 | 4.92 |
ENSMUST00000140251.9
|
Tsc22d1
|
TSC22 domain family, member 1 |
chr12_+_51640097 | 4.92 |
ENSMUST00000164782.10
ENSMUST00000085412.7 |
Coch
|
cochlin |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.4 | 38.2 | GO:0050757 | thymidylate synthase biosynthetic process(GO:0050757) regulation of thymidylate synthase biosynthetic process(GO:0050758) negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
6.3 | 19.0 | GO:0030824 | negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
6.0 | 18.0 | GO:0042694 | muscle cell fate specification(GO:0042694) |
4.0 | 19.8 | GO:1904048 | regulation of spontaneous neurotransmitter secretion(GO:1904048) |
3.6 | 14.3 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
3.5 | 10.5 | GO:0040040 | thermosensory behavior(GO:0040040) |
3.4 | 10.2 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
3.1 | 12.5 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
3.0 | 9.1 | GO:1904020 | regulation of G-protein coupled receptor internalization(GO:1904020) |
3.0 | 12.0 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
2.8 | 39.7 | GO:0098953 | receptor diffusion trapping(GO:0098953) postsynaptic neurotransmitter receptor diffusion trapping(GO:0098970) neurotransmitter receptor diffusion trapping(GO:0099628) |
2.8 | 2.8 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
2.8 | 8.4 | GO:0002588 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
2.7 | 11.0 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
2.7 | 2.7 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
2.6 | 10.5 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
2.6 | 7.9 | GO:0010232 | vascular transport(GO:0010232) milk ejection(GO:0060156) |
2.6 | 13.0 | GO:0046684 | response to pyrethroid(GO:0046684) |
2.5 | 2.5 | GO:0034118 | erythrocyte aggregation(GO:0034117) regulation of erythrocyte aggregation(GO:0034118) |
2.5 | 7.6 | GO:0015688 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
2.5 | 2.5 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
2.5 | 4.9 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
2.4 | 7.1 | GO:1990926 | short-term synaptic potentiation(GO:1990926) |
2.4 | 7.1 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
2.3 | 7.0 | GO:0015825 | L-serine transport(GO:0015825) |
2.3 | 11.6 | GO:0010747 | positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
2.3 | 13.9 | GO:0007412 | axon target recognition(GO:0007412) |
2.3 | 18.3 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) negative regulation of serotonin uptake(GO:0051612) |
2.3 | 9.1 | GO:0098961 | dendritic transport of ribonucleoprotein complex(GO:0098961) dendritic transport of messenger ribonucleoprotein complex(GO:0098963) anterograde dendritic transport of messenger ribonucleoprotein complex(GO:0098964) |
2.2 | 6.7 | GO:0036363 | transforming growth factor beta activation(GO:0036363) |
2.2 | 22.4 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
2.2 | 2.2 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
2.2 | 11.0 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
2.2 | 13.1 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
2.2 | 8.7 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
2.1 | 8.6 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
2.1 | 8.3 | GO:2001107 | negative regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001107) |
2.1 | 6.2 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
2.1 | 10.4 | GO:0086048 | membrane depolarization during bundle of His cell action potential(GO:0086048) |
2.1 | 2.1 | GO:0071874 | cellular response to norepinephrine stimulus(GO:0071874) |
2.1 | 14.4 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
2.0 | 8.2 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
2.0 | 12.2 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
2.0 | 4.1 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
2.0 | 2.0 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
2.0 | 14.1 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
2.0 | 10.1 | GO:1902163 | negative regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902163) |
2.0 | 5.9 | GO:0001966 | thigmotaxis(GO:0001966) |
2.0 | 5.9 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
2.0 | 5.9 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
2.0 | 9.8 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
1.9 | 7.8 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
1.9 | 5.7 | GO:0010615 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
1.9 | 7.5 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
1.9 | 13.1 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
1.9 | 11.2 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
1.8 | 25.9 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
1.8 | 7.4 | GO:1900149 | positive regulation of Schwann cell migration(GO:1900149) |
1.8 | 10.9 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
1.8 | 16.3 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
1.8 | 1.8 | GO:0061141 | lung ciliated cell differentiation(GO:0061141) |
1.8 | 10.8 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
1.8 | 10.8 | GO:0099551 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
1.8 | 14.3 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
1.8 | 17.8 | GO:0016198 | axon choice point recognition(GO:0016198) |
1.8 | 14.2 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
1.7 | 7.0 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
1.7 | 1.7 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
1.7 | 6.9 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
1.7 | 8.5 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
1.7 | 1.7 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
1.7 | 11.7 | GO:0061373 | mammillary body development(GO:0021767) mammillary axonal complex development(GO:0061373) positive regulation of lens fiber cell differentiation(GO:1902748) |
1.7 | 5.0 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
1.7 | 19.8 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
1.6 | 34.3 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
1.6 | 6.5 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
1.6 | 8.1 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
1.6 | 4.8 | GO:0033058 | directional locomotion(GO:0033058) |
1.6 | 12.7 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
1.6 | 9.4 | GO:0032423 | regulation of mismatch repair(GO:0032423) |
1.6 | 6.3 | GO:1904529 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
1.5 | 6.2 | GO:1903416 | response to glycoside(GO:1903416) |
1.5 | 12.3 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
1.5 | 18.5 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
1.5 | 4.6 | GO:0097401 | synaptic vesicle lumen acidification(GO:0097401) |
1.5 | 9.1 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
1.5 | 1.5 | GO:1900453 | negative regulation of long term synaptic depression(GO:1900453) |
1.5 | 6.1 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
1.5 | 9.1 | GO:1900085 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
1.5 | 4.5 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
1.5 | 3.0 | GO:0061642 | chemoattraction of axon(GO:0061642) |
1.5 | 6.0 | GO:0021933 | radial glia guided migration of cerebellar granule cell(GO:0021933) |
1.5 | 17.9 | GO:0046958 | nonassociative learning(GO:0046958) |
1.5 | 1.5 | GO:0032328 | alanine transport(GO:0032328) |
1.5 | 4.5 | GO:0006500 | N-terminal protein palmitoylation(GO:0006500) |
1.5 | 4.4 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
1.5 | 4.4 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
1.5 | 14.5 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
1.4 | 11.6 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
1.4 | 4.3 | GO:0002380 | immunoglobulin secretion involved in immune response(GO:0002380) |
1.4 | 5.7 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
1.4 | 8.6 | GO:2001023 | regulation of response to drug(GO:2001023) |
1.4 | 7.1 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
1.4 | 4.2 | GO:1903465 | motogenic signaling involved in postnatal olfactory bulb interneuron migration(GO:0021837) positive regulation of mitotic cell cycle DNA replication(GO:1903465) |
1.4 | 11.2 | GO:0060437 | lung growth(GO:0060437) |
1.4 | 8.3 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
1.4 | 18.1 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
1.4 | 2.8 | GO:0003347 | epicardial cell to mesenchymal cell transition(GO:0003347) |
1.4 | 5.5 | GO:2000588 | positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
1.4 | 13.8 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
1.4 | 5.5 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
1.4 | 2.7 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
1.4 | 6.8 | GO:0048691 | positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) |
1.4 | 4.1 | GO:0043973 | histone H3-K4 acetylation(GO:0043973) |
1.3 | 4.0 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
1.3 | 1.3 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
1.3 | 6.7 | GO:0072262 | metanephric glomerular mesangium development(GO:0072223) metanephric glomerular mesangial cell proliferation involved in metanephros development(GO:0072262) |
1.3 | 4.0 | GO:0060032 | notochord regression(GO:0060032) |
1.3 | 5.3 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
1.3 | 3.9 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) |
1.3 | 6.5 | GO:0001661 | conditioned taste aversion(GO:0001661) |
1.3 | 1.3 | GO:0035502 | metanephric part of ureteric bud development(GO:0035502) |
1.3 | 3.9 | GO:0043181 | vacuolar sequestering(GO:0043181) |
1.3 | 1.3 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
1.3 | 7.7 | GO:0072592 | oxygen metabolic process(GO:0072592) |
1.3 | 9.0 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
1.3 | 2.6 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
1.3 | 2.6 | GO:1902473 | regulation of protein localization to synapse(GO:1902473) |
1.3 | 1.3 | GO:0045402 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
1.3 | 2.5 | GO:0055095 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
1.3 | 5.0 | GO:1902081 | regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
1.3 | 10.0 | GO:0097646 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
1.2 | 3.7 | GO:0070099 | regulation of chemokine-mediated signaling pathway(GO:0070099) |
1.2 | 11.2 | GO:0036006 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
1.2 | 8.7 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
1.2 | 4.9 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
1.2 | 4.9 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
1.2 | 4.9 | GO:0030421 | defecation(GO:0030421) |
1.2 | 1.2 | GO:0060979 | vasculogenesis involved in coronary vascular morphogenesis(GO:0060979) |
1.2 | 3.6 | GO:0060912 | cardiac cell fate specification(GO:0060912) |
1.2 | 6.0 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
1.2 | 6.0 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
1.2 | 26.2 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
1.2 | 2.4 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
1.2 | 2.4 | GO:1903233 | regulation of calcium ion-dependent exocytosis of neurotransmitter(GO:1903233) |
1.2 | 11.8 | GO:0097117 | guanylate kinase-associated protein clustering(GO:0097117) |
1.2 | 4.7 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
1.2 | 4.7 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
1.2 | 4.7 | GO:0021750 | vestibular nucleus development(GO:0021750) |
1.2 | 9.3 | GO:1903564 | regulation of protein localization to cilium(GO:1903564) |
1.2 | 3.5 | GO:1904328 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
1.2 | 5.8 | GO:0090427 | activation of meiosis(GO:0090427) |
1.1 | 6.9 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
1.1 | 12.5 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
1.1 | 5.6 | GO:1905073 | occluding junction disassembly(GO:1905071) regulation of occluding junction disassembly(GO:1905073) positive regulation of occluding junction disassembly(GO:1905075) |
1.1 | 7.9 | GO:0098967 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
1.1 | 5.6 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
1.1 | 7.9 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
1.1 | 4.5 | GO:0007522 | visceral muscle development(GO:0007522) |
1.1 | 4.5 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
1.1 | 10.1 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
1.1 | 8.9 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
1.1 | 5.6 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
1.1 | 1.1 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
1.1 | 5.5 | GO:0046952 | ketone body catabolic process(GO:0046952) |
1.1 | 3.3 | GO:0061107 | seminal vesicle development(GO:0061107) |
1.1 | 12.0 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
1.1 | 4.3 | GO:1900533 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
1.1 | 3.2 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
1.1 | 9.7 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
1.1 | 3.2 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
1.1 | 1.1 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
1.1 | 4.3 | GO:0035425 | autocrine signaling(GO:0035425) |
1.1 | 12.8 | GO:0021694 | cerebellar Purkinje cell layer formation(GO:0021694) |
1.1 | 1.1 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
1.1 | 36.0 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
1.1 | 1.1 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
1.1 | 1.1 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
1.1 | 8.4 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
1.1 | 5.3 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
1.0 | 4.2 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
1.0 | 4.2 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
1.0 | 1.0 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
1.0 | 1.0 | GO:1904456 | negative regulation of neuronal action potential(GO:1904456) |
1.0 | 5.1 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
1.0 | 4.1 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
1.0 | 9.2 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
1.0 | 2.0 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
1.0 | 4.0 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
1.0 | 2.0 | GO:0072071 | mesangial cell differentiation(GO:0072007) glomerular mesangial cell differentiation(GO:0072008) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) |
1.0 | 7.9 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
1.0 | 7.9 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
1.0 | 2.9 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
1.0 | 3.9 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
1.0 | 2.9 | GO:0035934 | corticosterone secretion(GO:0035934) |
1.0 | 12.6 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
1.0 | 3.9 | GO:1904395 | positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
1.0 | 3.9 | GO:0036343 | psychomotor behavior(GO:0036343) |
1.0 | 5.8 | GO:1902988 | regulation of neuronal signal transduction(GO:1902847) neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
1.0 | 1.9 | GO:1903575 | cornified envelope assembly(GO:1903575) |
1.0 | 1.0 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
1.0 | 4.8 | GO:0098886 | modification of dendritic spine(GO:0098886) |
1.0 | 2.9 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
1.0 | 4.8 | GO:0001830 | trophectodermal cell fate commitment(GO:0001830) |
1.0 | 2.9 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
0.9 | 3.8 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
0.9 | 10.4 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.9 | 2.8 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.9 | 4.7 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.9 | 1.9 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.9 | 6.6 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.9 | 8.5 | GO:0071313 | cellular response to caffeine(GO:0071313) |
0.9 | 2.8 | GO:0003245 | cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
0.9 | 7.5 | GO:0036376 | sodium ion export from cell(GO:0036376) |
0.9 | 6.6 | GO:0009405 | pathogenesis(GO:0009405) |
0.9 | 6.6 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.9 | 5.6 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.9 | 5.6 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.9 | 0.9 | GO:0002030 | inhibitory G-protein coupled receptor phosphorylation(GO:0002030) |
0.9 | 1.9 | GO:0060857 | establishment of glial blood-brain barrier(GO:0060857) |
0.9 | 1.9 | GO:0035482 | gastric motility(GO:0035482) |
0.9 | 8.3 | GO:1903044 | protein localization to membrane raft(GO:1903044) |
0.9 | 25.8 | GO:0097435 | fibril organization(GO:0097435) |
0.9 | 2.8 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.9 | 3.7 | GO:0071544 | diphosphoinositol polyphosphate catabolic process(GO:0071544) |
0.9 | 31.2 | GO:0035640 | exploration behavior(GO:0035640) |
0.9 | 0.9 | GO:1903116 | positive regulation of actin filament-based movement(GO:1903116) |
0.9 | 2.7 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.9 | 0.9 | GO:0097324 | melanocyte migration(GO:0097324) |
0.9 | 43.8 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
0.9 | 2.7 | GO:1900135 | positive regulation of renin secretion into blood stream(GO:1900135) |
0.9 | 2.7 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
0.9 | 9.9 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.9 | 0.9 | GO:0071415 | cellular response to purine-containing compound(GO:0071415) |
0.9 | 2.7 | GO:0021664 | rhombomere formation(GO:0021594) rhombomere 3 formation(GO:0021660) rhombomere 5 morphogenesis(GO:0021664) rhombomere 5 formation(GO:0021666) |
0.9 | 1.8 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.9 | 8.9 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.9 | 16.9 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.9 | 2.7 | GO:0071929 | alpha-tubulin acetylation(GO:0071929) positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.9 | 3.6 | GO:0032899 | regulation of neurotrophin production(GO:0032899) positive regulation of neurotrophin production(GO:0032901) |
0.9 | 3.6 | GO:0003017 | lymph circulation(GO:0003017) |
0.9 | 4.4 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
0.9 | 5.3 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.9 | 2.6 | GO:0090172 | attachment of spindle microtubules to kinetochore involved in homologous chromosome segregation(GO:0051455) microtubule cytoskeleton organization involved in homologous chromosome segregation(GO:0090172) |
0.9 | 2.6 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
0.9 | 2.6 | GO:0014055 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) |
0.9 | 3.5 | GO:0046950 | cellular ketone body metabolic process(GO:0046950) |
0.9 | 1.7 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.9 | 87.3 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.9 | 0.9 | GO:0060854 | patterning of lymph vessels(GO:0060854) |
0.9 | 0.9 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.9 | 4.3 | GO:0098971 | anterograde dendritic transport of neurotransmitter receptor complex(GO:0098971) |
0.9 | 3.4 | GO:1905051 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
0.9 | 12.8 | GO:0099612 | protein localization to axon(GO:0099612) |
0.9 | 0.9 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.8 | 3.4 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.8 | 16.1 | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling(GO:0010882) |
0.8 | 30.5 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.8 | 8.5 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.8 | 2.5 | GO:0033082 | regulation of extrathymic T cell differentiation(GO:0033082) |
0.8 | 9.3 | GO:0060074 | synapse maturation(GO:0060074) |
0.8 | 1.7 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.8 | 4.2 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.8 | 2.5 | GO:2000668 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
0.8 | 4.2 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.8 | 6.7 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.8 | 3.3 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.8 | 1.7 | GO:2000078 | positive regulation of type B pancreatic cell development(GO:2000078) |
0.8 | 13.3 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.8 | 3.3 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.8 | 0.8 | GO:0086043 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.8 | 9.1 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.8 | 15.7 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.8 | 0.8 | GO:0032741 | positive regulation of interleukin-18 production(GO:0032741) |
0.8 | 4.9 | GO:0048069 | eye pigmentation(GO:0048069) |
0.8 | 2.5 | GO:1905161 | protein localization to phagocytic vesicle(GO:1905161) regulation of protein localization to phagocytic vesicle(GO:1905169) positive regulation of protein localization to phagocytic vesicle(GO:1905171) |
0.8 | 17.1 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.8 | 1.6 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
0.8 | 3.2 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.8 | 13.7 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.8 | 2.4 | GO:0034635 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.8 | 2.4 | GO:0051582 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.8 | 18.2 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
0.8 | 14.9 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.8 | 13.3 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.8 | 4.7 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.8 | 3.9 | GO:0035617 | stress granule disassembly(GO:0035617) |
0.8 | 3.9 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.8 | 6.2 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.8 | 2.3 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.8 | 3.1 | GO:1903525 | regulation of membrane tubulation(GO:1903525) positive regulation of membrane tubulation(GO:1903527) |
0.8 | 0.8 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.8 | 2.3 | GO:1904092 | regulation of autophagic cell death(GO:1904092) negative regulation of autophagic cell death(GO:1904093) |
0.8 | 19.2 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.8 | 3.1 | GO:1904453 | regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904451) positive regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904453) |
0.8 | 3.1 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.8 | 3.8 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.8 | 3.1 | GO:0044407 | biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
0.8 | 6.8 | GO:2001212 | regulation of vasculogenesis(GO:2001212) |
0.8 | 6.1 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.8 | 2.3 | GO:1901906 | diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
0.8 | 17.3 | GO:0071420 | response to histamine(GO:0034776) cellular response to histamine(GO:0071420) |
0.7 | 6.7 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.7 | 3.0 | GO:0006226 | dUMP biosynthetic process(GO:0006226) |
0.7 | 2.2 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
0.7 | 3.7 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.7 | 0.7 | GO:0072124 | glomerular mesangial cell proliferation(GO:0072110) regulation of glomerular mesangial cell proliferation(GO:0072124) |
0.7 | 2.9 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
0.7 | 4.4 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) positive regulation of platelet aggregation(GO:1901731) |
0.7 | 0.7 | GO:1900170 | negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
0.7 | 3.6 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
0.7 | 2.2 | GO:0045212 | neurotransmitter receptor biosynthetic process(GO:0045212) |
0.7 | 5.8 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.7 | 2.9 | GO:0022038 | corpus callosum development(GO:0022038) |
0.7 | 12.9 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.7 | 3.6 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.7 | 5.7 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.7 | 4.3 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.7 | 5.7 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
0.7 | 2.8 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.7 | 2.1 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.7 | 15.5 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.7 | 2.1 | GO:0072720 | response to dithiothreitol(GO:0072720) |
0.7 | 4.9 | GO:0061591 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.7 | 6.3 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.7 | 16.7 | GO:1905144 | acetylcholine receptor signaling pathway(GO:0095500) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.7 | 11.1 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.7 | 3.5 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
0.7 | 2.1 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.7 | 2.8 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.7 | 6.9 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.7 | 1.4 | GO:2001201 | regulation of transforming growth factor-beta secretion(GO:2001201) |
0.7 | 6.9 | GO:0032264 | IMP salvage(GO:0032264) |
0.7 | 2.1 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.7 | 0.7 | GO:0033029 | regulation of neutrophil apoptotic process(GO:0033029) negative regulation of neutrophil apoptotic process(GO:0033030) |
0.7 | 4.1 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.7 | 0.7 | GO:1903365 | regulation of fear response(GO:1903365) regulation of behavioral fear response(GO:2000822) |
0.7 | 2.0 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
0.7 | 23.8 | GO:0007616 | long-term memory(GO:0007616) |
0.7 | 2.7 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
0.7 | 4.7 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.7 | 3.4 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.7 | 2.0 | GO:0045763 | negative regulation of cellular amino acid metabolic process(GO:0045763) |
0.7 | 1.3 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
0.7 | 2.0 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
0.7 | 0.7 | GO:0098534 | centriole assembly(GO:0098534) |
0.7 | 2.0 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
0.7 | 4.0 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.7 | 1.3 | GO:0086098 | angiotensin-activated signaling pathway involved in heart process(GO:0086098) |
0.7 | 1.3 | GO:0035470 | positive regulation of vascular wound healing(GO:0035470) regulation of vascular wound healing(GO:0061043) |
0.7 | 9.8 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.7 | 2.6 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
0.7 | 15.0 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.6 | 24.6 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.6 | 0.6 | GO:0072166 | posterior mesonephric tubule development(GO:0072166) |
0.6 | 1.9 | GO:2000547 | regulation of dendritic cell dendrite assembly(GO:2000547) |
0.6 | 2.6 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.6 | 1.9 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.6 | 1.3 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.6 | 1.9 | GO:0070376 | regulation of ERK5 cascade(GO:0070376) |
0.6 | 34.0 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.6 | 0.6 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.6 | 2.6 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.6 | 5.7 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.6 | 0.6 | GO:0051542 | elastin biosynthetic process(GO:0051542) |
0.6 | 3.2 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.6 | 3.8 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.6 | 1.2 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.6 | 32.5 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
0.6 | 1.9 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.6 | 1.8 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.6 | 1.2 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.6 | 1.8 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.6 | 1.2 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.6 | 0.6 | GO:2000973 | pro-B cell differentiation(GO:0002328) regulation of pro-B cell differentiation(GO:2000973) |
0.6 | 6.6 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.6 | 3.6 | GO:0035989 | tendon development(GO:0035989) |
0.6 | 3.0 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.6 | 3.6 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.6 | 0.6 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.6 | 0.6 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.6 | 4.1 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.6 | 6.5 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.6 | 1.2 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.6 | 26.9 | GO:0070528 | protein kinase C signaling(GO:0070528) |
0.6 | 4.1 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.6 | 1.2 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
0.6 | 2.9 | GO:0051451 | myoblast migration(GO:0051451) |
0.6 | 1.7 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.6 | 22.6 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.6 | 2.9 | GO:0006116 | NADH oxidation(GO:0006116) |
0.6 | 5.8 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.6 | 2.3 | GO:1901003 | regulation of fermentation(GO:0043465) negative regulation of fermentation(GO:1901003) |
0.6 | 17.3 | GO:2001259 | positive regulation of cation channel activity(GO:2001259) |
0.6 | 16.1 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.6 | 3.4 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.6 | 7.5 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.6 | 2.9 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
0.6 | 23.3 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
0.6 | 0.6 | GO:0045829 | negative regulation of isotype switching(GO:0045829) |
0.6 | 4.5 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.6 | 2.3 | GO:0071899 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.6 | 3.4 | GO:0015824 | proline transport(GO:0015824) |
0.6 | 1.1 | GO:0045112 | integrin biosynthetic process(GO:0045112) regulation of integrin biosynthetic process(GO:0045113) |
0.6 | 1.7 | GO:0033605 | positive regulation of catecholamine secretion(GO:0033605) |
0.6 | 1.1 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.6 | 0.6 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.6 | 1.7 | GO:0033577 | protein glycosylation in endoplasmic reticulum(GO:0033577) |
0.6 | 1.7 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.6 | 0.6 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.5 | 1.6 | GO:0051885 | positive regulation of anagen(GO:0051885) |
0.5 | 1.6 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.5 | 1.6 | GO:0061439 | renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) |
0.5 | 1.1 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
0.5 | 11.4 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.5 | 2.2 | GO:0035106 | operant conditioning(GO:0035106) |
0.5 | 1.6 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.5 | 25.9 | GO:1901379 | regulation of potassium ion transmembrane transport(GO:1901379) |
0.5 | 2.2 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
0.5 | 8.1 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.5 | 1.6 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
0.5 | 0.5 | GO:0033684 | regulation of luteinizing hormone secretion(GO:0033684) positive regulation of luteinizing hormone secretion(GO:0033686) |
0.5 | 4.8 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.5 | 2.1 | GO:0000390 | spliceosomal complex disassembly(GO:0000390) |
0.5 | 2.1 | GO:0003360 | brainstem development(GO:0003360) |
0.5 | 2.1 | GO:0045636 | regulation of melanocyte differentiation(GO:0045634) positive regulation of melanocyte differentiation(GO:0045636) |
0.5 | 0.5 | GO:0070092 | regulation of glucagon secretion(GO:0070092) |
0.5 | 5.9 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.5 | 4.8 | GO:0015671 | oxygen transport(GO:0015671) |
0.5 | 1.6 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.5 | 2.6 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.5 | 1.6 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.5 | 1.6 | GO:0021740 | trigeminal sensory nucleus development(GO:0021730) principal sensory nucleus of trigeminal nerve development(GO:0021740) |
0.5 | 1.5 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.5 | 10.3 | GO:0034063 | stress granule assembly(GO:0034063) |
0.5 | 4.1 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.5 | 1.0 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.5 | 1.5 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.5 | 7.1 | GO:0007614 | short-term memory(GO:0007614) |
0.5 | 1.0 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.5 | 1.5 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.5 | 5.1 | GO:2001197 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.5 | 11.6 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.5 | 1.5 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.5 | 5.1 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.5 | 2.0 | GO:1990091 | sodium-dependent self proteolysis(GO:1990091) |
0.5 | 7.0 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.5 | 2.5 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
0.5 | 4.0 | GO:0002568 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
0.5 | 2.0 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.5 | 2.0 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.5 | 2.0 | GO:2000016 | negative regulation of determination of dorsal identity(GO:2000016) |
0.5 | 3.4 | GO:0006868 | glutamine transport(GO:0006868) |
0.5 | 5.9 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.5 | 19.7 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.5 | 1.0 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.5 | 1.9 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.5 | 1.5 | GO:0015817 | histidine transport(GO:0015817) |
0.5 | 5.8 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.5 | 0.5 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.5 | 1.4 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.5 | 1.0 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.5 | 1.0 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.5 | 2.9 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.5 | 2.4 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.5 | 2.3 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.5 | 1.4 | GO:0090673 | endothelial cell-matrix adhesion(GO:0090673) |
0.5 | 3.7 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.5 | 1.4 | GO:0002371 | dendritic cell cytokine production(GO:0002371) regulation of dendritic cell cytokine production(GO:0002730) |
0.5 | 1.9 | GO:0032222 | regulation of synaptic transmission, cholinergic(GO:0032222) positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.5 | 4.2 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.5 | 1.4 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.5 | 1.4 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.5 | 3.2 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.5 | 0.5 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
0.5 | 1.8 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.5 | 1.8 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.5 | 2.3 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.5 | 11.3 | GO:0001553 | luteinization(GO:0001553) |
0.4 | 0.4 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.4 | 0.4 | GO:0021764 | amygdala development(GO:0021764) |
0.4 | 3.1 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.4 | 1.8 | GO:0051140 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.4 | 2.2 | GO:0097104 | postsynaptic membrane assembly(GO:0097104) |
0.4 | 1.8 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.4 | 1.3 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.4 | 1.8 | GO:0032888 | regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
0.4 | 1.7 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.4 | 1.7 | GO:0070343 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
0.4 | 2.6 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.4 | 3.9 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.4 | 3.0 | GO:0030578 | PML body organization(GO:0030578) |
0.4 | 1.3 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.4 | 1.3 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.4 | 1.3 | GO:0007315 | oocyte construction(GO:0007308) oocyte axis specification(GO:0007309) oocyte anterior/posterior axis specification(GO:0007314) pole plasm assembly(GO:0007315) maternal determination of anterior/posterior axis, embryo(GO:0008358) P granule organization(GO:0030719) |
0.4 | 0.9 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.4 | 5.1 | GO:2000576 | positive regulation of microtubule motor activity(GO:2000576) |
0.4 | 2.6 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.4 | 4.7 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
0.4 | 2.1 | GO:0038032 | termination of G-protein coupled receptor signaling pathway(GO:0038032) |
0.4 | 0.4 | GO:0098935 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
0.4 | 1.7 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
0.4 | 2.1 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.4 | 0.8 | GO:0060179 | male mating behavior(GO:0060179) |
0.4 | 0.4 | GO:1901074 | regulation of engulfment of apoptotic cell(GO:1901074) |
0.4 | 1.7 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.4 | 1.2 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.4 | 2.5 | GO:0060082 | response to carbon monoxide(GO:0034465) eye blink reflex(GO:0060082) |
0.4 | 10.7 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.4 | 2.5 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.4 | 8.6 | GO:0060291 | long-term synaptic potentiation(GO:0060291) |
0.4 | 3.2 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.4 | 1.6 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.4 | 0.4 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.4 | 0.8 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.4 | 0.8 | GO:1901490 | regulation of lymphangiogenesis(GO:1901490) positive regulation of lymphangiogenesis(GO:1901492) |
0.4 | 1.6 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.4 | 1.2 | GO:0060618 | nipple development(GO:0060618) |
0.4 | 5.6 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.4 | 2.0 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.4 | 1.6 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.4 | 2.0 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.4 | 6.3 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.4 | 9.9 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.4 | 0.4 | GO:2000407 | regulation of T cell extravasation(GO:2000407) positive regulation of T cell extravasation(GO:2000409) |
0.4 | 2.4 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.4 | 8.6 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.4 | 0.4 | GO:0046710 | GDP metabolic process(GO:0046710) |
0.4 | 2.3 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.4 | 1.9 | GO:2000437 | regulation of monocyte extravasation(GO:2000437) positive regulation of monocyte extravasation(GO:2000439) |
0.4 | 9.7 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.4 | 19.7 | GO:0099504 | synaptic vesicle cycle(GO:0099504) |
0.4 | 0.8 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.4 | 0.4 | GO:0071725 | response to diacyl bacterial lipopeptide(GO:0071724) response to triacyl bacterial lipopeptide(GO:0071725) cellular response to diacyl bacterial lipopeptide(GO:0071726) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.4 | 8.8 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.4 | 1.5 | GO:0033580 | protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
0.4 | 1.1 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.4 | 0.8 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.4 | 1.5 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.4 | 1.5 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.4 | 2.7 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.4 | 0.8 | GO:0014908 | myotube differentiation involved in skeletal muscle regeneration(GO:0014908) |
0.4 | 4.1 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.4 | 1.1 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.4 | 7.5 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.4 | 1.5 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.4 | 4.5 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) |
0.4 | 5.6 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.4 | 3.4 | GO:0048102 | autophagic cell death(GO:0048102) |
0.4 | 0.7 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.4 | 2.6 | GO:0030818 | negative regulation of cyclic nucleotide biosynthetic process(GO:0030803) negative regulation of cAMP biosynthetic process(GO:0030818) |
0.4 | 4.4 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.4 | 4.8 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.4 | 3.3 | GO:0021815 | modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration(GO:0021815) |
0.4 | 7.0 | GO:0061318 | renal filtration cell differentiation(GO:0061318) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.4 | 1.5 | GO:0010636 | positive regulation of mitochondrial fusion(GO:0010636) |
0.4 | 1.8 | GO:0070829 | heterochromatin maintenance(GO:0070829) |
0.4 | 0.7 | GO:0032056 | positive regulation of translation in response to stress(GO:0032056) |
0.4 | 2.9 | GO:0009098 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
0.4 | 0.7 | GO:0099640 | axo-dendritic protein transport(GO:0099640) |
0.4 | 3.2 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.4 | 2.2 | GO:0034184 | positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.4 | 5.4 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.4 | 3.6 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.4 | 2.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.4 | 1.4 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.4 | 2.1 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.4 | 3.2 | GO:0090177 | establishment of planar polarity involved in neural tube closure(GO:0090177) |
0.4 | 0.4 | GO:0035332 | positive regulation of hippo signaling(GO:0035332) |
0.4 | 1.8 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.4 | 0.7 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
0.4 | 0.7 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.3 | 5.9 | GO:0008542 | visual learning(GO:0008542) |
0.3 | 1.7 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.3 | 2.8 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.3 | 3.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.3 | 1.4 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.3 | 3.8 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.3 | 2.8 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) positive regulation of membrane depolarization(GO:1904181) |
0.3 | 4.8 | GO:0032060 | bleb assembly(GO:0032060) |
0.3 | 8.3 | GO:0043113 | receptor clustering(GO:0043113) |
0.3 | 1.0 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
0.3 | 2.1 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
0.3 | 0.7 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.3 | 2.4 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.3 | 5.1 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.3 | 2.7 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
0.3 | 7.8 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.3 | 1.7 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.3 | 0.3 | GO:0090004 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.3 | 1.3 | GO:0098582 | innate vocalization behavior(GO:0098582) |
0.3 | 1.0 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.3 | 0.3 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.3 | 1.3 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
0.3 | 1.0 | GO:0072553 | terminal button organization(GO:0072553) |
0.3 | 1.0 | GO:0010705 | meiotic DNA double-strand break processing involved in reciprocal meiotic recombination(GO:0010705) |
0.3 | 1.3 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.3 | 0.3 | GO:0001941 | postsynaptic membrane organization(GO:0001941) |
0.3 | 10.8 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.3 | 3.9 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.3 | 5.9 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.3 | 0.3 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.3 | 13.9 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.3 | 0.3 | GO:0001575 | globoside metabolic process(GO:0001575) |
0.3 | 0.6 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.3 | 1.0 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.3 | 11.2 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.3 | 14.0 | GO:0099643 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
0.3 | 4.5 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.3 | 5.7 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.3 | 1.3 | GO:0030974 | thiamine pyrophosphate transport(GO:0030974) |
0.3 | 14.2 | GO:0098840 | protein transport along microtubule(GO:0098840) |
0.3 | 0.6 | GO:0048105 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
0.3 | 0.3 | GO:0072368 | regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter(GO:0072368) |
0.3 | 0.6 | GO:0006788 | heme oxidation(GO:0006788) |
0.3 | 0.3 | GO:0060821 | inactivation of X chromosome by DNA methylation(GO:0060821) |
0.3 | 0.9 | GO:0048822 | enucleate erythrocyte development(GO:0048822) |
0.3 | 1.9 | GO:0006735 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
0.3 | 0.9 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.3 | 2.8 | GO:0007525 | somatic muscle development(GO:0007525) |
0.3 | 3.4 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.3 | 0.6 | GO:0042045 | epithelial fluid transport(GO:0042045) |
0.3 | 1.5 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.3 | 3.1 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.3 | 1.5 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
0.3 | 1.2 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.3 | 5.5 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.3 | 0.9 | GO:1903912 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.3 | 3.4 | GO:0021955 | central nervous system neuron axonogenesis(GO:0021955) |
0.3 | 0.9 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.3 | 1.2 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
0.3 | 4.3 | GO:0050806 | positive regulation of synaptic transmission(GO:0050806) |
0.3 | 0.6 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.3 | 0.9 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
0.3 | 2.1 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.3 | 0.3 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.3 | 0.6 | GO:0034164 | negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
0.3 | 0.3 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.3 | 1.8 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.3 | 1.8 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.3 | 2.7 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.3 | 0.6 | GO:0002320 | lymphoid progenitor cell differentiation(GO:0002320) |
0.3 | 0.3 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
0.3 | 2.3 | GO:0002931 | response to ischemia(GO:0002931) |
0.3 | 1.5 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.3 | 1.5 | GO:0048866 | stem cell fate commitment(GO:0048865) stem cell fate specification(GO:0048866) |
0.3 | 7.0 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.3 | 0.3 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.3 | 0.6 | GO:0070417 | cellular response to cold(GO:0070417) |
0.3 | 0.9 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.3 | 2.0 | GO:0015705 | iodide transport(GO:0015705) |
0.3 | 0.3 | GO:0042275 | error-free postreplication DNA repair(GO:0042275) |
0.3 | 4.6 | GO:0051647 | nucleus localization(GO:0051647) |
0.3 | 0.8 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.3 | 2.8 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.3 | 0.8 | GO:0033189 | response to vitamin A(GO:0033189) |
0.3 | 3.4 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.3 | 2.2 | GO:1990090 | response to nerve growth factor(GO:1990089) cellular response to nerve growth factor stimulus(GO:1990090) |
0.3 | 4.2 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.3 | 0.3 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.3 | 0.6 | GO:2000313 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.3 | 0.8 | GO:0043366 | beta selection(GO:0043366) |
0.3 | 2.5 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.3 | 0.3 | GO:1904925 | positive regulation of macromitophagy(GO:1901526) regulation of mitophagy in response to mitochondrial depolarization(GO:1904923) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
0.3 | 1.1 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.3 | 1.9 | GO:0042891 | antibiotic transport(GO:0042891) |
0.3 | 6.3 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.3 | 1.6 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.3 | 5.5 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.3 | 0.8 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.3 | 1.1 | GO:0051031 | tRNA transport(GO:0051031) |
0.3 | 0.8 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
0.3 | 0.8 | GO:0071476 | cellular hypotonic response(GO:0071476) |
0.3 | 5.4 | GO:0001675 | acrosome assembly(GO:0001675) |
0.3 | 18.8 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.3 | 0.8 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.3 | 5.6 | GO:0097479 | synaptic vesicle localization(GO:0097479) |
0.3 | 0.8 | GO:0051350 | negative regulation of lyase activity(GO:0051350) |
0.3 | 1.3 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.3 | 7.4 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.3 | 3.2 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.3 | 7.1 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.3 | 2.1 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.3 | 1.6 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.3 | 3.9 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.3 | 1.8 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.3 | 0.3 | GO:0003177 | pulmonary valve development(GO:0003177) pulmonary valve morphogenesis(GO:0003184) |
0.3 | 1.3 | GO:0051932 | synaptic transmission, GABAergic(GO:0051932) |
0.3 | 0.8 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.3 | 1.5 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.3 | 3.8 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.2 | 0.7 | GO:0033967 | box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
0.2 | 1.2 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.2 | 0.5 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
0.2 | 0.5 | GO:0070194 | synaptonemal complex disassembly(GO:0070194) |
0.2 | 1.0 | GO:0044359 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.2 | 0.2 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.2 | 0.5 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.2 | 0.7 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.2 | 0.7 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.2 | 0.5 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
0.2 | 0.2 | GO:0060676 | ureteric bud formation(GO:0060676) |
0.2 | 2.9 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.2 | 1.2 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) |
0.2 | 1.7 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.2 | 0.5 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.2 | 1.2 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.2 | 0.5 | GO:0061197 | fungiform papilla development(GO:0061196) fungiform papilla morphogenesis(GO:0061197) |
0.2 | 0.2 | GO:1904849 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.2 | 1.2 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.2 | 0.9 | GO:0050973 | detection of mechanical stimulus involved in equilibrioception(GO:0050973) |
0.2 | 1.2 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.2 | 0.2 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
0.2 | 2.1 | GO:0042053 | regulation of dopamine metabolic process(GO:0042053) regulation of catecholamine metabolic process(GO:0042069) |
0.2 | 0.2 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.2 | 10.4 | GO:2001240 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
0.2 | 0.5 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.2 | 0.5 | GO:0007228 | signal transduction downstream of smoothened(GO:0007227) positive regulation of hh target transcription factor activity(GO:0007228) |
0.2 | 1.2 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.2 | 0.7 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.2 | 0.9 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
0.2 | 0.9 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.2 | 0.5 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.2 | 1.1 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.2 | 0.7 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.2 | 1.1 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.2 | 1.1 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.2 | 0.6 | GO:0035638 | patched ligand maturation(GO:0007225) signal maturation(GO:0035638) |
0.2 | 9.7 | GO:0034605 | cellular response to heat(GO:0034605) |
0.2 | 0.2 | GO:0019417 | sulfur oxidation(GO:0019417) |
0.2 | 0.6 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.2 | 1.9 | GO:0000012 | single strand break repair(GO:0000012) |
0.2 | 0.9 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.2 | 1.1 | GO:2001223 | negative regulation of neuron migration(GO:2001223) |
0.2 | 2.1 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.2 | 0.6 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.2 | 1.1 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.2 | 0.6 | GO:0006267 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
0.2 | 1.7 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.2 | 0.2 | GO:0072319 | vesicle uncoating(GO:0072319) |
0.2 | 0.6 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.2 | 1.0 | GO:0033275 | actin-myosin filament sliding(GO:0033275) |
0.2 | 0.6 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.2 | 2.5 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.2 | 5.3 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.2 | 9.2 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.2 | 1.0 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.2 | 0.6 | GO:0010359 | regulation of anion channel activity(GO:0010359) |
0.2 | 1.4 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.2 | 5.4 | GO:0072698 | protein localization to microtubule cytoskeleton(GO:0072698) |
0.2 | 1.0 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.2 | 2.4 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.2 | 6.5 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.2 | 2.6 | GO:2000400 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.2 | 1.2 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.2 | 1.2 | GO:1903755 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
0.2 | 0.2 | GO:0035655 | interleukin-18-mediated signaling pathway(GO:0035655) cellular response to interleukin-18(GO:0071351) |
0.2 | 1.9 | GO:0031110 | regulation of microtubule polymerization or depolymerization(GO:0031110) |
0.2 | 2.3 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.2 | 1.5 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.2 | 0.6 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.2 | 4.6 | GO:0042596 | fear response(GO:0042596) |
0.2 | 0.6 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
0.2 | 0.9 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.2 | 0.2 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.2 | 2.3 | GO:2000232 | regulation of rRNA processing(GO:2000232) |
0.2 | 0.8 | GO:1902167 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902167) |
0.2 | 0.6 | GO:0030472 | mitotic spindle organization in nucleus(GO:0030472) |
0.2 | 1.9 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
0.2 | 16.1 | GO:0050770 | regulation of axonogenesis(GO:0050770) |
0.2 | 0.9 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.2 | 2.4 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.2 | 0.9 | GO:0098712 | L-glutamate import across plasma membrane(GO:0098712) |
0.2 | 0.7 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.2 | 0.5 | GO:0051030 | snRNA transport(GO:0051030) |
0.2 | 1.1 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.2 | 0.9 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.2 | 0.4 | GO:0006649 | phospholipid transfer to membrane(GO:0006649) |
0.2 | 2.2 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.2 | 3.6 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.2 | 0.5 | GO:0000349 | generation of catalytic spliceosome for first transesterification step(GO:0000349) |
0.2 | 1.8 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.2 | 0.5 | GO:0030961 | peptidyl-arginine hydroxylation(GO:0030961) |
0.2 | 0.9 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
0.2 | 1.1 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.2 | 1.6 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.2 | 0.7 | GO:0018343 | protein farnesylation(GO:0018343) |
0.2 | 0.4 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.2 | 0.7 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.2 | 0.5 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
0.2 | 0.9 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.2 | 0.7 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.2 | 0.7 | GO:0032725 | positive regulation of granulocyte macrophage colony-stimulating factor production(GO:0032725) |
0.2 | 1.4 | GO:0043585 | nose morphogenesis(GO:0043585) alveolar primary septum development(GO:0061143) |
0.2 | 0.2 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.2 | 1.2 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.2 | 0.7 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.2 | 0.7 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.2 | 1.2 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.2 | 4.6 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.2 | 1.5 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.2 | 0.8 | GO:0018202 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.2 | 0.3 | GO:1905155 | positive regulation of phagocytosis, engulfment(GO:0060100) positive regulation of membrane invagination(GO:1905155) |
0.2 | 1.0 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.2 | 0.8 | GO:1904976 | response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
0.2 | 0.5 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.2 | 3.3 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.2 | 0.3 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.2 | 0.3 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.2 | 1.1 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.2 | 1.6 | GO:0003283 | atrial septum development(GO:0003283) |
0.2 | 1.5 | GO:1902400 | signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) |
0.2 | 0.2 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
0.2 | 0.5 | GO:0015966 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
0.2 | 0.6 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.2 | 1.5 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
0.2 | 0.3 | GO:0006589 | octopamine biosynthetic process(GO:0006589) octopamine metabolic process(GO:0046333) |
0.2 | 0.3 | GO:0072695 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.2 | 1.4 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.2 | 0.3 | GO:1903539 | protein localization to postsynaptic membrane(GO:1903539) |
0.2 | 1.1 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.2 | 0.5 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.2 | 0.2 | GO:0046101 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.2 | 5.4 | GO:0051298 | centrosome duplication(GO:0051298) |
0.2 | 2.3 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.2 | 1.1 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
0.2 | 0.6 | GO:0032298 | positive regulation of DNA-dependent DNA replication initiation(GO:0032298) |
0.2 | 3.8 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.2 | 3.4 | GO:1904357 | negative regulation of telomere maintenance via telomere lengthening(GO:1904357) |
0.2 | 0.6 | GO:0015846 | polyamine transport(GO:0015846) |
0.2 | 5.3 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.2 | 0.9 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.2 | 0.5 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.1 | 1.5 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.1 | 1.6 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.1 | 0.1 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.1 | 0.4 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.1 | 1.2 | GO:0051255 | spindle midzone assembly(GO:0051255) |
0.1 | 6.4 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.3 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
0.1 | 0.6 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.1 | 0.7 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 0.4 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.1 | 3.4 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 0.3 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.1 | 1.3 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
0.1 | 0.1 | GO:0072434 | signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
0.1 | 0.6 | GO:0010934 | macrophage cytokine production(GO:0010934) regulation of macrophage cytokine production(GO:0010935) |
0.1 | 1.8 | GO:0072599 | establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.1 | 1.3 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.1 | 0.4 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.1 | 0.3 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
0.1 | 10.3 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.1 | 1.0 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.1 | 0.7 | GO:0051458 | corticotropin secretion(GO:0051458) |
0.1 | 0.4 | GO:0048478 | replication fork protection(GO:0048478) |
0.1 | 1.1 | GO:0016322 | neuron remodeling(GO:0016322) |
0.1 | 0.3 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.1 | 3.2 | GO:0044782 | cilium organization(GO:0044782) |
0.1 | 0.4 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.5 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.1 | 0.4 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.1 | 1.1 | GO:0046549 | retinal cone cell development(GO:0046549) |
0.1 | 1.6 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.1 | 1.1 | GO:0036337 | Fas signaling pathway(GO:0036337) |
0.1 | 0.8 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.1 | 0.8 | GO:2001205 | negative regulation of osteoclast development(GO:2001205) |
0.1 | 0.5 | GO:0018201 | peptidyl-glycine modification(GO:0018201) |
0.1 | 0.3 | GO:0019614 | catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
0.1 | 0.1 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.1 | 0.7 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.1 | 0.3 | GO:0045842 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.1 | 0.7 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.1 | 1.4 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.1 | 1.0 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.1 | 1.8 | GO:0051225 | spindle assembly(GO:0051225) |
0.1 | 1.1 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.4 | GO:0019085 | early viral transcription(GO:0019085) |
0.1 | 9.8 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.1 | 0.5 | GO:0086103 | glucocorticoid mediated signaling pathway(GO:0043402) G-protein coupled receptor signaling pathway involved in heart process(GO:0086103) |
0.1 | 0.4 | GO:0040010 | positive regulation of growth rate(GO:0040010) |
0.1 | 0.1 | GO:0045794 | negative regulation of cell volume(GO:0045794) |
0.1 | 0.2 | GO:0036216 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.1 | 1.4 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.6 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.1 | 1.2 | GO:0060004 | reflex(GO:0060004) |
0.1 | 0.6 | GO:0051138 | positive regulation of NK T cell differentiation(GO:0051138) |
0.1 | 0.4 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 0.4 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.1 | 3.0 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.1 | 0.5 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 1.7 | GO:0097049 | motor neuron apoptotic process(GO:0097049) |
0.1 | 1.3 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 1.0 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.1 | 0.4 | GO:0019389 | glucuronoside metabolic process(GO:0019389) |
0.1 | 1.5 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.1 | 0.5 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.1 | 0.1 | GO:0001546 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.1 | 0.7 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 1.4 | GO:0006903 | vesicle targeting(GO:0006903) |
0.1 | 0.6 | GO:0097309 | cap1 mRNA methylation(GO:0097309) |
0.1 | 0.3 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.1 | 0.7 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.1 | 1.0 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 0.5 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.1 | 3.4 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.1 | 1.8 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.1 | 1.0 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.1 | 0.3 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.1 | 0.4 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.1 | 1.4 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.1 | 2.9 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.1 | 0.4 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.1 | 0.3 | GO:2000501 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.1 | 2.6 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.1 | 0.1 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.1 | 0.9 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.1 | 0.2 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
0.1 | 0.3 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.1 | 0.2 | GO:0034970 | histone H3-R2 methylation(GO:0034970) |
0.1 | 0.5 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.1 | 1.3 | GO:0038202 | TORC1 signaling(GO:0038202) |
0.1 | 0.7 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.1 | 0.2 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.1 | 1.1 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.1 | 0.4 | GO:0002432 | granuloma formation(GO:0002432) |
0.1 | 3.3 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.1 | 0.7 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.1 | 0.4 | GO:0021564 | vagus nerve development(GO:0021564) |
0.1 | 0.7 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.1 | 0.9 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.1 | 0.3 | GO:0030070 | insulin processing(GO:0030070) |
0.1 | 0.6 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.1 | 1.4 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.1 | 0.3 | GO:0002946 | tRNA C5-cytosine methylation(GO:0002946) |
0.1 | 0.4 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) |
0.1 | 1.5 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 1.0 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.1 | 0.3 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
0.1 | 0.3 | GO:0051714 | regulation of cytolysis in other organism(GO:0051710) positive regulation of cytolysis in other organism(GO:0051714) |
0.1 | 0.3 | GO:0006235 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.1 | 0.8 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.1 | 1.9 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.1 | 1.2 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.1 | 1.7 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.1 | 0.8 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.1 | 3.3 | GO:0006813 | potassium ion transport(GO:0006813) |
0.1 | 0.2 | GO:0071816 | tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.1 | 0.2 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.1 | 0.8 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.1 | 1.0 | GO:0048278 | vesicle docking(GO:0048278) |
0.1 | 0.7 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) |
0.1 | 0.3 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
0.1 | 0.4 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 0.2 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
0.1 | 0.7 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 1.0 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 0.5 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.1 | 1.4 | GO:0031100 | organ regeneration(GO:0031100) |
0.1 | 1.4 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.1 | 0.8 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.1 | 0.6 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.1 | 0.3 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 0.4 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.1 | 0.6 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 0.1 | GO:0039692 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) |
0.1 | 0.2 | GO:1905077 | negative regulation of interleukin-17 secretion(GO:1905077) |
0.1 | 0.3 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.1 | 0.2 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.1 | 0.5 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.1 | 0.5 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.1 | 0.4 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.1 | 0.1 | GO:0009644 | response to high light intensity(GO:0009644) |
0.1 | 0.4 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
0.1 | 0.1 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.1 | 0.4 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.1 | 0.9 | GO:0032735 | positive regulation of interleukin-12 production(GO:0032735) |
0.1 | 0.2 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.1 | 0.9 | GO:0008347 | glial cell migration(GO:0008347) |
0.1 | 14.5 | GO:0051056 | regulation of small GTPase mediated signal transduction(GO:0051056) |
0.1 | 0.3 | GO:0035660 | MyD88-dependent toll-like receptor 4 signaling pathway(GO:0035660) |
0.1 | 1.1 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.1 | 0.2 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) |
0.1 | 0.8 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.1 | 0.1 | GO:0019046 | release from viral latency(GO:0019046) |
0.1 | 0.1 | GO:0061743 | motor learning(GO:0061743) |
0.1 | 0.3 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.1 | 1.4 | GO:0098927 | vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.1 | 0.2 | GO:0031590 | wybutosine metabolic process(GO:0031590) wybutosine biosynthetic process(GO:0031591) |
0.1 | 0.4 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.1 | 2.1 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.1 | 1.5 | GO:0035065 | regulation of histone acetylation(GO:0035065) |
0.1 | 0.1 | GO:0002586 | regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
0.1 | 0.4 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.1 | 0.2 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.1 | 0.6 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.6 | GO:0006312 | mitotic recombination(GO:0006312) |
0.1 | 1.2 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 0.1 | GO:1903487 | regulation of lactation(GO:1903487) |
0.1 | 1.4 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.1 | 0.2 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.1 | 1.7 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 0.4 | GO:0032324 | molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 0.2 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.1 | 0.2 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.1 | 0.2 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.1 | 0.4 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
0.1 | 0.2 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.1 | 0.3 | GO:0002645 | positive regulation of tolerance induction(GO:0002645) |
0.1 | 0.1 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.1 | 0.1 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.1 | 1.0 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.1 | 0.2 | GO:0002155 | regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.1 | 0.1 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.1 | 0.3 | GO:0080009 | mRNA methylation(GO:0080009) |
0.1 | 0.2 | GO:1901563 | response to camptothecin(GO:1901563) |
0.1 | 0.2 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.2 | GO:0001964 | startle response(GO:0001964) |
0.1 | 0.5 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
0.1 | 0.4 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.1 | 0.4 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.0 | 0.4 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.0 | 0.1 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.0 | 0.1 | GO:0000237 | leptotene(GO:0000237) |
0.0 | 0.1 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
0.0 | 0.4 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.0 | 0.4 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.0 | 1.1 | GO:0045687 | positive regulation of glial cell differentiation(GO:0045687) |
0.0 | 0.2 | GO:1904247 | positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
0.0 | 0.3 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.0 | 2.2 | GO:0071806 | intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
0.0 | 0.2 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.0 | 0.9 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.0 | 0.3 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.0 | 0.3 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.0 | 0.3 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.0 | 0.1 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.0 | 2.0 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.2 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.0 | 0.2 | GO:0046504 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.0 | 1.6 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.0 | 0.4 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.0 | 0.2 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.0 | 0.1 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
0.0 | 0.4 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.0 | 0.3 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.0 | 0.2 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) |
0.0 | 0.1 | GO:0097475 | motor neuron migration(GO:0097475) |
0.0 | 0.6 | GO:0006298 | mismatch repair(GO:0006298) |
0.0 | 0.1 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.0 | 0.6 | GO:0071230 | cellular response to amino acid stimulus(GO:0071230) |
0.0 | 0.7 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.0 | 0.4 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.0 | 0.2 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.1 | GO:0097384 | cellular lipid biosynthetic process(GO:0097384) |
0.0 | 0.1 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.0 | 0.1 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
0.0 | 0.1 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
0.0 | 0.1 | GO:2000197 | regulation of ribonucleoprotein complex localization(GO:2000197) |
0.0 | 0.2 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.0 | 0.2 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
0.0 | 1.8 | GO:0007018 | microtubule-based movement(GO:0007018) |
0.0 | 0.4 | GO:1990138 | neuron projection extension(GO:1990138) |
0.0 | 0.1 | GO:0070781 | protein biotinylation(GO:0009305) response to biotin(GO:0070781) histone biotinylation(GO:0071110) |
0.0 | 0.1 | GO:0048263 | determination of dorsal/ventral asymmetry(GO:0048262) determination of dorsal identity(GO:0048263) |
0.0 | 0.1 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.0 | 0.1 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
0.0 | 0.1 | GO:0045077 | negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
0.0 | 0.2 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.0 | GO:0035973 | aggrephagy(GO:0035973) |
0.0 | 0.1 | GO:0006972 | hyperosmotic response(GO:0006972) |
0.0 | 0.1 | GO:0071718 | sodium-independent icosanoid transport(GO:0071718) |
0.0 | 0.2 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.0 | 0.6 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.0 | 0.2 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.0 | 0.1 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.0 | 0.1 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.0 | 0.3 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.1 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.0 | 0.1 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.0 | 0.4 | GO:0007612 | learning(GO:0007612) |
0.0 | 0.0 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.0 | 0.0 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
0.0 | 0.1 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.0 | 0.0 | GO:0036509 | trimming of terminal mannose on B branch(GO:0036509) |
0.0 | 0.2 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.0 | 0.7 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 0.1 | GO:0036093 | germ cell proliferation(GO:0036093) |
0.0 | 0.0 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.2 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.0 | 0.0 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.0 | 0.1 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.2 | 46.7 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
4.0 | 16.1 | GO:0014802 | terminal cisterna(GO:0014802) |
3.8 | 11.3 | GO:1902912 | pyruvate kinase complex(GO:1902912) |
3.2 | 3.2 | GO:0061673 | mitotic spindle astral microtubule(GO:0061673) |
3.2 | 9.5 | GO:0098830 | presynaptic endosome(GO:0098830) |
3.1 | 15.6 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
3.1 | 15.3 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
3.0 | 62.6 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
3.0 | 44.7 | GO:0044327 | dendritic spine head(GO:0044327) |
2.8 | 14.1 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
2.8 | 11.0 | GO:1990769 | proximal neuron projection(GO:1990769) |
2.6 | 10.6 | GO:0043511 | inhibin complex(GO:0043511) |
2.5 | 12.7 | GO:0044308 | axonal spine(GO:0044308) |
2.3 | 35.1 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
2.3 | 9.1 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
2.2 | 8.7 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
2.1 | 39.4 | GO:0097512 | cardiac myofibril(GO:0097512) |
2.0 | 18.3 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
2.0 | 15.9 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
1.9 | 5.6 | GO:0005584 | collagen type I trimer(GO:0005584) |
1.8 | 3.7 | GO:0044305 | calyx of Held(GO:0044305) |
1.8 | 83.8 | GO:0032590 | dendrite membrane(GO:0032590) |
1.8 | 9.1 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
1.8 | 23.2 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
1.7 | 5.1 | GO:1990031 | pinceau fiber(GO:1990031) |
1.7 | 10.0 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
1.6 | 24.5 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
1.6 | 6.4 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
1.5 | 10.7 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
1.5 | 51.1 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
1.4 | 2.9 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
1.4 | 5.7 | GO:0060171 | stereocilium membrane(GO:0060171) |
1.4 | 4.2 | GO:0090537 | CERF complex(GO:0090537) |
1.3 | 2.6 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
1.3 | 31.4 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
1.3 | 11.6 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
1.3 | 5.1 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
1.2 | 16.8 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
1.2 | 4.8 | GO:0097444 | spine apparatus(GO:0097444) |
1.2 | 15.2 | GO:0097427 | microtubule bundle(GO:0097427) |
1.1 | 3.4 | GO:0034774 | secretory granule lumen(GO:0034774) cytoplasmic membrane-bounded vesicle lumen(GO:0060205) |
1.1 | 27.4 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
1.1 | 20.5 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
1.1 | 19.2 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
1.1 | 4.5 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
1.1 | 5.6 | GO:1990130 | Iml1 complex(GO:1990130) |
1.1 | 3.3 | GO:0044302 | dentate gyrus mossy fiber(GO:0044302) |
1.1 | 5.4 | GO:0098890 | extrinsic component of presynaptic membrane(GO:0098888) extrinsic component of postsynaptic membrane(GO:0098890) |
1.1 | 17.4 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
1.1 | 4.2 | GO:0032589 | neuron projection membrane(GO:0032589) |
1.1 | 1.1 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
1.1 | 8.4 | GO:0008091 | spectrin(GO:0008091) |
1.0 | 18.6 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
1.0 | 8.3 | GO:0030314 | junctional membrane complex(GO:0030314) |
1.0 | 19.5 | GO:0035253 | ciliary rootlet(GO:0035253) |
1.0 | 4.1 | GO:0099573 | glutamatergic postsynaptic density(GO:0099573) |
1.0 | 6.2 | GO:0033270 | paranode region of axon(GO:0033270) |
1.0 | 26.4 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
1.0 | 3.0 | GO:0060187 | cell pole(GO:0060187) |
1.0 | 10.0 | GO:0043083 | synaptic cleft(GO:0043083) |
1.0 | 1.0 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
1.0 | 8.9 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
1.0 | 45.3 | GO:0048786 | presynaptic active zone(GO:0048786) |
1.0 | 5.8 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.9 | 28.4 | GO:0043194 | axon initial segment(GO:0043194) |
0.9 | 11.8 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.9 | 2.7 | GO:0016014 | dystrobrevin complex(GO:0016014) |
0.9 | 0.9 | GO:0005593 | FACIT collagen trimer(GO:0005593) collagen type IX trimer(GO:0005594) |
0.9 | 3.5 | GO:0042642 | actomyosin, myosin complex part(GO:0042642) |
0.9 | 2.6 | GO:1990879 | CST complex(GO:1990879) |
0.8 | 2.5 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.8 | 4.2 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.8 | 3.4 | GO:0072534 | perineuronal net(GO:0072534) |
0.8 | 85.8 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.8 | 3.3 | GO:0097447 | dendritic tree(GO:0097447) |
0.8 | 13.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.8 | 10.7 | GO:0005861 | troponin complex(GO:0005861) |
0.8 | 12.1 | GO:0031209 | SCAR complex(GO:0031209) |
0.8 | 5.6 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.8 | 2.4 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.8 | 3.9 | GO:0031310 | integral component of vacuolar membrane(GO:0031166) intrinsic component of vacuolar membrane(GO:0031310) |
0.8 | 5.4 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.8 | 3.1 | GO:0097574 | lateral part of cell(GO:0097574) basolateral part of cell(GO:1990794) rod bipolar cell terminal bouton(GO:1990795) |
0.8 | 6.9 | GO:0005883 | neurofilament(GO:0005883) |
0.8 | 65.8 | GO:0043198 | dendritic shaft(GO:0043198) |
0.8 | 2.3 | GO:0048179 | activin receptor complex(GO:0048179) |
0.8 | 2.3 | GO:1902560 | GMP reductase complex(GO:1902560) |
0.7 | 2.2 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
0.7 | 5.2 | GO:0005955 | calcineurin complex(GO:0005955) |
0.7 | 19.7 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.7 | 9.4 | GO:0097450 | astrocyte end-foot(GO:0097450) |
0.7 | 5.1 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.7 | 67.4 | GO:0016528 | sarcoplasm(GO:0016528) |
0.7 | 18.1 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.7 | 20.6 | GO:0031527 | filopodium membrane(GO:0031527) |
0.7 | 4.7 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.7 | 2.7 | GO:0071953 | elastic fiber(GO:0071953) |
0.7 | 34.0 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.6 | 7.8 | GO:0001520 | outer dense fiber(GO:0001520) |
0.6 | 1.9 | GO:0005668 | RNA polymerase transcription factor SL1 complex(GO:0005668) |
0.6 | 3.2 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.6 | 2.5 | GO:0071920 | cleavage body(GO:0071920) |
0.6 | 3.8 | GO:0031673 | H zone(GO:0031673) |
0.6 | 3.1 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.6 | 7.4 | GO:0072687 | meiotic spindle(GO:0072687) |
0.6 | 4.9 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.6 | 1.8 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
0.6 | 1.8 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.6 | 10.2 | GO:0036038 | MKS complex(GO:0036038) |
0.6 | 1.8 | GO:0032545 | CURI complex(GO:0032545) UTP-C complex(GO:0034456) |
0.6 | 8.9 | GO:0045180 | basal cortex(GO:0045180) |
0.6 | 4.8 | GO:0033269 | internode region of axon(GO:0033269) |
0.6 | 18.9 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.6 | 3.5 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.6 | 18.0 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.6 | 11.0 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.6 | 7.4 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.5 | 1.6 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.5 | 1.6 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.5 | 3.7 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.5 | 3.1 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.5 | 16.6 | GO:0030990 | intraciliary transport particle(GO:0030990) |
0.5 | 25.3 | GO:0044295 | axonal growth cone(GO:0044295) |
0.5 | 3.1 | GO:0000235 | astral microtubule(GO:0000235) |
0.5 | 1.5 | GO:0016939 | kinesin II complex(GO:0016939) |
0.5 | 0.5 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
0.5 | 9.0 | GO:0005916 | fascia adherens(GO:0005916) |
0.5 | 4.0 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.5 | 3.5 | GO:0044292 | dendrite terminus(GO:0044292) |
0.5 | 14.7 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.5 | 1.5 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.5 | 0.5 | GO:0019034 | viral replication complex(GO:0019034) |
0.5 | 0.5 | GO:0043291 | RAVE complex(GO:0043291) |
0.5 | 13.9 | GO:0097546 | ciliary base(GO:0097546) |
0.5 | 1.4 | GO:0034705 | potassium channel complex(GO:0034705) |
0.5 | 60.1 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.5 | 142.7 | GO:0014069 | postsynaptic density(GO:0014069) |
0.5 | 2.3 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.5 | 8.2 | GO:0044298 | cell body membrane(GO:0044298) |
0.4 | 1.8 | GO:1990298 | mitotic checkpoint complex(GO:0033597) bub1-bub3 complex(GO:1990298) |
0.4 | 4.8 | GO:0097542 | ciliary tip(GO:0097542) |
0.4 | 4.8 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.4 | 2.2 | GO:0000799 | nuclear condensin complex(GO:0000799) |
0.4 | 1.7 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.4 | 1.3 | GO:0031904 | endosome lumen(GO:0031904) |
0.4 | 2.6 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.4 | 4.2 | GO:0036157 | outer dynein arm(GO:0036157) |
0.4 | 2.1 | GO:0043203 | axon hillock(GO:0043203) |
0.4 | 1.2 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.4 | 2.8 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.4 | 0.4 | GO:0044449 | contractile fiber part(GO:0044449) |
0.4 | 1.2 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.4 | 2.8 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.4 | 2.8 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.4 | 25.6 | GO:0045171 | intercellular bridge(GO:0045171) |
0.4 | 9.8 | GO:0097440 | apical dendrite(GO:0097440) |
0.4 | 0.8 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.4 | 0.4 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.4 | 6.9 | GO:0060076 | excitatory synapse(GO:0060076) |
0.4 | 1.1 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.4 | 2.6 | GO:0034709 | methylosome(GO:0034709) |
0.4 | 0.7 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.4 | 8.1 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.4 | 2.5 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.4 | 11.2 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.4 | 11.8 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.4 | 3.2 | GO:0097255 | R2TP complex(GO:0097255) |
0.4 | 1.8 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.4 | 19.5 | GO:0043195 | terminal bouton(GO:0043195) |
0.4 | 10.9 | GO:0001891 | phagocytic cup(GO:0001891) |
0.4 | 21.5 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.4 | 3.2 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.3 | 17.8 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.3 | 1.7 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.3 | 32.3 | GO:0030018 | Z disc(GO:0030018) |
0.3 | 3.4 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.3 | 2.0 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.3 | 2.7 | GO:0098793 | presynapse(GO:0098793) |
0.3 | 9.4 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.3 | 2.0 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.3 | 8.7 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.3 | 0.7 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.3 | 3.0 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.3 | 1.0 | GO:0034677 | integrin alpha7-beta1 complex(GO:0034677) |
0.3 | 134.4 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.3 | 2.6 | GO:0002177 | manchette(GO:0002177) |
0.3 | 9.8 | GO:0071565 | nBAF complex(GO:0071565) |
0.3 | 1.3 | GO:0071797 | LUBAC complex(GO:0071797) |
0.3 | 3.5 | GO:0031045 | dense core granule(GO:0031045) |
0.3 | 5.4 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.3 | 1.3 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.3 | 2.2 | GO:0089701 | U2AF(GO:0089701) |
0.3 | 2.2 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.3 | 0.3 | GO:0034681 | integrin alpha11-beta1 complex(GO:0034681) |
0.3 | 1.5 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.3 | 1.8 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.3 | 17.3 | GO:0044309 | neuron spine(GO:0044309) |
0.3 | 8.8 | GO:0002102 | podosome(GO:0002102) |
0.3 | 3.9 | GO:0034464 | BBSome(GO:0034464) |
0.3 | 0.9 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.3 | 19.8 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.3 | 1.2 | GO:0042583 | chromaffin granule(GO:0042583) |
0.3 | 5.4 | GO:0097228 | sperm principal piece(GO:0097228) |
0.3 | 0.8 | GO:0055087 | Ski complex(GO:0055087) |
0.3 | 12.9 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.3 | 1.6 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.3 | 0.5 | GO:0005683 | U7 snRNP(GO:0005683) |
0.3 | 4.0 | GO:0000124 | SAGA complex(GO:0000124) |
0.3 | 4.6 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.2 | 1.2 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.2 | 1.0 | GO:1990752 | microtubule end(GO:1990752) |
0.2 | 3.5 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.2 | 1.5 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.2 | 24.7 | GO:0044853 | plasma membrane raft(GO:0044853) |
0.2 | 6.9 | GO:0005682 | U5 snRNP(GO:0005682) |
0.2 | 0.7 | GO:1990696 | USH2 complex(GO:1990696) |
0.2 | 2.8 | GO:0005869 | dynactin complex(GO:0005869) |
0.2 | 0.7 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
0.2 | 1.4 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
0.2 | 27.9 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.2 | 29.4 | GO:0030427 | site of polarized growth(GO:0030427) |
0.2 | 0.7 | GO:0097224 | sperm connecting piece(GO:0097224) |
0.2 | 2.4 | GO:0071546 | pi-body(GO:0071546) |
0.2 | 0.6 | GO:0034455 | t-UTP complex(GO:0034455) |
0.2 | 20.1 | GO:0005814 | centriole(GO:0005814) |
0.2 | 0.4 | GO:0044094 | host cell nucleus(GO:0042025) host cell nuclear part(GO:0044094) |
0.2 | 0.6 | GO:0036387 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
0.2 | 0.8 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.2 | 0.6 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
0.2 | 0.4 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.2 | 0.4 | GO:0000125 | PCAF complex(GO:0000125) |
0.2 | 0.6 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.2 | 7.0 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 2.6 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.2 | 1.2 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
0.2 | 4.9 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.2 | 1.7 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.2 | 1.0 | GO:0035976 | AP1 complex(GO:0035976) |
0.2 | 1.5 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.2 | 1.3 | GO:0036396 | MIS complex(GO:0036396) |
0.2 | 0.8 | GO:0070820 | tertiary granule(GO:0070820) |
0.2 | 0.9 | GO:1990745 | EARP complex(GO:1990745) |
0.2 | 1.7 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.2 | 3.6 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.2 | 0.6 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
0.2 | 3.3 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.2 | 0.7 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
0.2 | 3.3 | GO:0051233 | spindle midzone(GO:0051233) |
0.2 | 1.1 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.2 | 1.3 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.2 | 6.6 | GO:0016235 | aggresome(GO:0016235) |
0.2 | 2.3 | GO:0000242 | pericentriolar material(GO:0000242) |
0.2 | 4.6 | GO:1902562 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.2 | 2.5 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.2 | 7.1 | GO:0035861 | site of double-strand break(GO:0035861) |
0.2 | 13.8 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.2 | 8.4 | GO:0072686 | mitotic spindle(GO:0072686) |
0.2 | 0.7 | GO:1990393 | 3M complex(GO:1990393) |
0.2 | 1.7 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.2 | 3.6 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.2 | 1.0 | GO:0071437 | invadopodium(GO:0071437) |
0.2 | 1.7 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.2 | 2.0 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.2 | 3.3 | GO:0031672 | A band(GO:0031672) |
0.2 | 5.5 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.2 | 13.5 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.2 | 3.3 | GO:0035102 | PRC1 complex(GO:0035102) |
0.2 | 0.5 | GO:0070985 | TFIIK complex(GO:0070985) |
0.2 | 0.3 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.2 | 1.2 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.2 | 1.4 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.2 | 1.2 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.2 | 0.8 | GO:0045179 | apical cortex(GO:0045179) |
0.2 | 34.2 | GO:0045202 | synapse(GO:0045202) |
0.2 | 8.0 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.1 | 21.5 | GO:0043209 | myelin sheath(GO:0043209) |
0.1 | 2.1 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 2.3 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 26.5 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.1 | GO:0002944 | cyclin K-CDK12 complex(GO:0002944) |
0.1 | 0.9 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 4.6 | GO:0005871 | kinesin complex(GO:0005871) |
0.1 | 1.5 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 0.7 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 0.6 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.1 | 1.5 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 11.1 | GO:0030016 | myofibril(GO:0030016) |
0.1 | 0.7 | GO:0051286 | cell tip(GO:0051286) |
0.1 | 1.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 0.4 | GO:0034066 | RIC1-RGP1 guanyl-nucleotide exchange factor complex(GO:0034066) |
0.1 | 1.2 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.1 | 2.4 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 5.6 | GO:0000922 | spindle pole(GO:0000922) |
0.1 | 2.3 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 6.5 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.1 | 1.0 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 1.8 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 31.4 | GO:0031252 | cell leading edge(GO:0031252) |
0.1 | 0.4 | GO:0030870 | Mre11 complex(GO:0030870) |
0.1 | 0.5 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.1 | 0.1 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
0.1 | 0.8 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 0.1 | GO:0002142 | stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.1 | 0.2 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
0.1 | 16.0 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.1 | 1.5 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 1.1 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.1 | 4.5 | GO:0097014 | ciliary plasm(GO:0097014) |
0.1 | 0.4 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 0.3 | GO:0034657 | GID complex(GO:0034657) |
0.1 | 0.7 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 0.4 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.1 | 0.6 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.1 | 0.8 | GO:0070847 | core mediator complex(GO:0070847) |
0.1 | 0.2 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 2.5 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.1 | 2.6 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 0.4 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 0.8 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.1 | 0.4 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 0.2 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 0.7 | GO:0000974 | Prp19 complex(GO:0000974) |
0.1 | 0.2 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.1 | 0.3 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.1 | 0.2 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.1 | 0.1 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.1 | 0.3 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.1 | 0.2 | GO:0097144 | BAX complex(GO:0097144) |
0.1 | 2.3 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 0.3 | GO:0031251 | PAN complex(GO:0031251) |
0.1 | 0.6 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 0.5 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.1 | 0.2 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
0.1 | 4.1 | GO:0000776 | kinetochore(GO:0000776) |
0.1 | 0.1 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.1 | 0.3 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.1 | 0.7 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.1 | 0.3 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.1 | 0.7 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 0.7 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.1 | 0.2 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 0.5 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 0.7 | GO:0032153 | cell division site(GO:0032153) cell division site part(GO:0032155) |
0.0 | 0.1 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.7 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.1 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.0 | 1.4 | GO:0001741 | XY body(GO:0001741) |
0.0 | 0.6 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.4 | GO:0033263 | CORVET complex(GO:0033263) |
0.0 | 1.8 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.2 | GO:0000796 | condensin complex(GO:0000796) |
0.0 | 0.0 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.0 | 0.4 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.0 | 0.3 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.0 | 0.4 | GO:0001939 | female pronucleus(GO:0001939) |
0.0 | 0.3 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.0 | 0.1 | GO:0000438 | core TFIIH complex portion of holo TFIIH complex(GO:0000438) |
0.0 | 1.4 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.0 | 0.4 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 0.0 | GO:0034680 | integrin alpha10-beta1 complex(GO:0034680) |
0.0 | 1.4 | GO:0036064 | ciliary basal body(GO:0036064) |
0.0 | 0.2 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.0 | 0.5 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 0.3 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.1 | GO:0016460 | myosin II complex(GO:0016460) |
0.0 | 0.3 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.0 | 0.1 | GO:0043614 | multi-eIF complex(GO:0043614) |
0.0 | 0.2 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.0 | 0.2 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.2 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.0 | 0.4 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 0.0 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
0.0 | 0.1 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
0.0 | 0.2 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.0 | 0.2 | GO:0071203 | WASH complex(GO:0071203) |
0.0 | 0.1 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.0 | 0.6 | GO:0031902 | late endosome membrane(GO:0031902) |
0.0 | 0.1 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
0.0 | 0.3 | GO:0005684 | U2-type spliceosomal complex(GO:0005684) |
0.0 | 0.1 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.0 | 0.1 | GO:0070545 | PeBoW complex(GO:0070545) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.2 | 36.2 | GO:0031812 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
3.5 | 10.4 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
3.2 | 12.8 | GO:0038025 | reelin receptor activity(GO:0038025) |
3.1 | 25.1 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
3.1 | 9.2 | GO:0086057 | voltage-gated calcium channel activity involved in bundle of His cell action potential(GO:0086057) |
3.0 | 24.3 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
3.0 | 12.0 | GO:0002153 | steroid receptor RNA activator RNA binding(GO:0002153) |
3.0 | 24.0 | GO:0034235 | GPI anchor binding(GO:0034235) |
2.8 | 14.1 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
2.6 | 15.7 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
2.6 | 12.9 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
2.4 | 17.1 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
2.3 | 16.4 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
2.3 | 9.3 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) |
2.1 | 8.4 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
2.1 | 10.4 | GO:0097001 | ceramide binding(GO:0097001) |
2.1 | 10.3 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
2.1 | 8.2 | GO:0070052 | collagen V binding(GO:0070052) |
1.9 | 9.7 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
1.9 | 7.7 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
1.9 | 19.1 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
1.9 | 5.7 | GO:0004615 | phosphomannomutase activity(GO:0004615) |
1.9 | 13.1 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
1.8 | 14.4 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
1.8 | 8.9 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
1.7 | 7.0 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
1.7 | 5.2 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
1.7 | 5.2 | GO:0035939 | microsatellite binding(GO:0035939) |
1.7 | 13.6 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
1.7 | 3.4 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
1.7 | 10.0 | GO:0097643 | amylin receptor activity(GO:0097643) |
1.7 | 5.0 | GO:0004373 | glycogen (starch) synthase activity(GO:0004373) |
1.7 | 5.0 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
1.6 | 11.5 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
1.6 | 4.9 | GO:0016492 | G-protein coupled neurotensin receptor activity(GO:0016492) |
1.6 | 9.8 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
1.6 | 14.6 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
1.6 | 11.1 | GO:0030172 | troponin C binding(GO:0030172) |
1.6 | 15.7 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
1.5 | 9.2 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
1.5 | 9.2 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
1.5 | 1.5 | GO:0050785 | advanced glycation end-product receptor activity(GO:0050785) |
1.5 | 6.1 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
1.5 | 9.1 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
1.5 | 13.4 | GO:0034711 | inhibin binding(GO:0034711) |
1.5 | 17.8 | GO:0032051 | clathrin light chain binding(GO:0032051) |
1.5 | 8.8 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
1.4 | 10.1 | GO:0086075 | gap junction channel activity involved in cardiac conduction electrical coupling(GO:0086075) |
1.4 | 8.6 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
1.4 | 10.0 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
1.4 | 17.0 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
1.4 | 5.5 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
1.4 | 32.7 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
1.4 | 6.8 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
1.3 | 4.0 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
1.3 | 4.0 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
1.3 | 6.6 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
1.3 | 43.4 | GO:0048156 | tau protein binding(GO:0048156) |
1.3 | 9.2 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
1.3 | 6.5 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
1.3 | 3.8 | GO:0010428 | methyl-CpNpG binding(GO:0010428) |
1.3 | 3.8 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
1.3 | 6.3 | GO:0030284 | estrogen receptor activity(GO:0030284) |
1.3 | 5.0 | GO:0005093 | Rab GDP-dissociation inhibitor activity(GO:0005093) |
1.2 | 12.5 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
1.2 | 5.0 | GO:0072591 | citrate-L-glutamate ligase activity(GO:0072591) |
1.2 | 9.9 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
1.2 | 17.2 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
1.2 | 24.3 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
1.2 | 7.3 | GO:0048495 | Roundabout binding(GO:0048495) |
1.2 | 4.8 | GO:1902379 | chemoattractant activity involved in axon guidance(GO:1902379) |
1.2 | 3.6 | GO:0031687 | A2A adenosine receptor binding(GO:0031687) |
1.2 | 7.2 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
1.2 | 16.8 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
1.2 | 3.6 | GO:0071820 | N-box binding(GO:0071820) |
1.2 | 3.5 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
1.2 | 4.7 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
1.2 | 5.8 | GO:0051373 | FATZ binding(GO:0051373) |
1.1 | 1.1 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
1.1 | 10.2 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
1.1 | 4.4 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
1.1 | 9.9 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
1.1 | 3.3 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
1.1 | 11.9 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
1.1 | 15.0 | GO:0034595 | phosphatidylinositol phosphate 5-phosphatase activity(GO:0034595) |
1.1 | 7.5 | GO:0031014 | troponin T binding(GO:0031014) |
1.1 | 3.2 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
1.1 | 5.3 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
1.0 | 12.4 | GO:0019992 | diacylglycerol binding(GO:0019992) |
1.0 | 21.7 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
1.0 | 5.1 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
1.0 | 10.3 | GO:0036310 | annealing helicase activity(GO:0036310) |
1.0 | 9.1 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
1.0 | 3.0 | GO:0035500 | MH2 domain binding(GO:0035500) |
1.0 | 16.1 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
1.0 | 4.0 | GO:0003883 | CTP synthase activity(GO:0003883) |
1.0 | 22.0 | GO:0016917 | GABA receptor activity(GO:0016917) |
1.0 | 29.0 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
1.0 | 4.0 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
1.0 | 9.0 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
1.0 | 3.0 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
1.0 | 14.7 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
1.0 | 3.9 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
1.0 | 8.8 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
1.0 | 9.7 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
1.0 | 8.7 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
1.0 | 3.8 | GO:0070051 | fibrinogen binding(GO:0070051) |
1.0 | 2.9 | GO:0004968 | gonadotropin-releasing hormone receptor activity(GO:0004968) |
0.9 | 10.4 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.9 | 2.8 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) corticotropin-releasing hormone receptor activity(GO:0043404) |
0.9 | 3.7 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.9 | 9.3 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.9 | 2.8 | GO:0005135 | interleukin-3 receptor binding(GO:0005135) |
0.9 | 11.1 | GO:0008061 | chitin binding(GO:0008061) |
0.9 | 17.2 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.9 | 3.6 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.9 | 4.5 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.9 | 8.1 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.9 | 9.7 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.9 | 0.9 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.9 | 2.6 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.9 | 6.9 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.9 | 8.6 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.9 | 7.7 | GO:0098988 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
0.9 | 7.7 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.9 | 4.3 | GO:1990188 | euchromatin binding(GO:1990188) |
0.8 | 5.9 | GO:0034431 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
0.8 | 4.2 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.8 | 2.5 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
0.8 | 6.7 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.8 | 23.4 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.8 | 19.4 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.8 | 11.3 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.8 | 2.4 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.8 | 39.2 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.8 | 4.7 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.8 | 13.3 | GO:0005522 | profilin binding(GO:0005522) |
0.8 | 28.8 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.8 | 16.2 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.8 | 2.3 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.8 | 10.0 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.8 | 2.3 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
0.8 | 3.0 | GO:0008386 | cholesterol monooxygenase (side-chain-cleaving) activity(GO:0008386) |
0.8 | 2.3 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
0.7 | 3.0 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.7 | 5.2 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.7 | 0.7 | GO:0036009 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
0.7 | 10.4 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.7 | 27.3 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.7 | 11.0 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.7 | 4.4 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.7 | 1.5 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.7 | 2.1 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
0.7 | 2.8 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
0.7 | 2.1 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.7 | 2.1 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
0.7 | 11.7 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.7 | 4.1 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.7 | 7.5 | GO:0033691 | sialic acid binding(GO:0033691) |
0.7 | 38.9 | GO:0050699 | WW domain binding(GO:0050699) |
0.7 | 0.7 | GO:0072590 | N-acetyl-L-aspartate-L-glutamate ligase activity(GO:0072590) |
0.7 | 2.7 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.7 | 14.1 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.7 | 2.7 | GO:0045159 | myosin II binding(GO:0045159) |
0.7 | 0.7 | GO:0032093 | SAM domain binding(GO:0032093) |
0.7 | 2.7 | GO:0034597 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
0.7 | 19.4 | GO:0030552 | cAMP binding(GO:0030552) |
0.7 | 4.0 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.7 | 0.7 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
0.7 | 3.9 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.7 | 28.8 | GO:0003785 | actin monomer binding(GO:0003785) |
0.6 | 1.9 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.6 | 3.2 | GO:0099609 | microtubule lateral binding(GO:0099609) |
0.6 | 9.0 | GO:0030274 | LIM domain binding(GO:0030274) |
0.6 | 6.4 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.6 | 4.4 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.6 | 6.3 | GO:0070538 | oleic acid binding(GO:0070538) |
0.6 | 11.4 | GO:0015026 | coreceptor activity(GO:0015026) |
0.6 | 4.4 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.6 | 1.9 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.6 | 8.1 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.6 | 14.8 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.6 | 1.8 | GO:0019948 | SUMO activating enzyme activity(GO:0019948) |
0.6 | 3.7 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
0.6 | 0.6 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.6 | 3.0 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.6 | 34.3 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.6 | 1.2 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.6 | 3.6 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.6 | 4.2 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.6 | 2.4 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
0.6 | 2.4 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.6 | 1.2 | GO:0097677 | STAT family protein binding(GO:0097677) |
0.6 | 2.3 | GO:0004096 | catalase activity(GO:0004096) |
0.6 | 34.5 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.6 | 2.9 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.6 | 1.7 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.6 | 2.3 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
0.6 | 13.6 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.6 | 2.3 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.6 | 2.8 | GO:0004051 | arachidonate 5-lipoxygenase activity(GO:0004051) |
0.6 | 7.3 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.6 | 2.2 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.6 | 1.7 | GO:0031370 | eukaryotic initiation factor 4G binding(GO:0031370) |
0.6 | 13.8 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.5 | 53.0 | GO:0005518 | collagen binding(GO:0005518) |
0.5 | 2.2 | GO:0004337 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
0.5 | 1.6 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.5 | 1.6 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.5 | 5.4 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.5 | 1.6 | GO:0016872 | inositol-3-phosphate synthase activity(GO:0004512) intramolecular lyase activity(GO:0016872) |
0.5 | 2.1 | GO:0070736 | protein-glycine ligase activity, initiating(GO:0070736) |
0.5 | 16.6 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.5 | 5.9 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.5 | 4.8 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.5 | 3.2 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.5 | 37.0 | GO:0019894 | kinesin binding(GO:0019894) |
0.5 | 4.2 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.5 | 0.5 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.5 | 41.0 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.5 | 1.6 | GO:0038100 | nodal binding(GO:0038100) |
0.5 | 3.7 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.5 | 1.6 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.5 | 1.0 | GO:0002135 | CTP binding(GO:0002135) sulfonylurea receptor binding(GO:0017098) |
0.5 | 5.2 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.5 | 3.6 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
0.5 | 6.1 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.5 | 1.5 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.5 | 3.6 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.5 | 1.5 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
0.5 | 8.0 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.5 | 2.5 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.5 | 3.5 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.5 | 3.0 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.5 | 2.9 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.5 | 1.0 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.5 | 9.8 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.5 | 1.9 | GO:0048030 | disaccharide binding(GO:0048030) |
0.5 | 9.2 | GO:0015643 | toxic substance binding(GO:0015643) |
0.5 | 1.4 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.5 | 1.4 | GO:0098782 | mechanically-gated potassium channel activity(GO:0098782) |
0.5 | 1.9 | GO:0051381 | histamine binding(GO:0051381) |
0.5 | 15.6 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.5 | 8.5 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.5 | 17.4 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.5 | 5.1 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.5 | 0.9 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.5 | 0.9 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.5 | 4.6 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.5 | 3.2 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.5 | 5.5 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.5 | 6.4 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.5 | 3.2 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.5 | 9.6 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.5 | 2.3 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.5 | 1.8 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.5 | 4.5 | GO:0038191 | neuropilin binding(GO:0038191) |
0.4 | 0.9 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
0.4 | 1.3 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.4 | 1.3 | GO:0004019 | adenylosuccinate synthase activity(GO:0004019) |
0.4 | 4.9 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.4 | 9.7 | GO:0031489 | myosin V binding(GO:0031489) |
0.4 | 3.0 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.4 | 2.2 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.4 | 2.2 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.4 | 1.7 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.4 | 3.5 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.4 | 7.3 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.4 | 7.7 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.4 | 1.7 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
0.4 | 1.3 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.4 | 6.0 | GO:0051378 | serotonin binding(GO:0051378) |
0.4 | 14.1 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.4 | 2.1 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
0.4 | 5.9 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.4 | 2.1 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.4 | 2.9 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
0.4 | 0.8 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
0.4 | 54.0 | GO:0044325 | ion channel binding(GO:0044325) |
0.4 | 2.5 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.4 | 9.2 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.4 | 1.3 | GO:0016232 | HNK-1 sulfotransferase activity(GO:0016232) |
0.4 | 26.2 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.4 | 2.1 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.4 | 3.3 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.4 | 1.6 | GO:0047710 | bis(5'-adenosyl)-triphosphatase activity(GO:0047710) |
0.4 | 4.0 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.4 | 1.6 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.4 | 0.8 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.4 | 0.8 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.4 | 2.0 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.4 | 6.7 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.4 | 3.1 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.4 | 30.9 | GO:0030276 | clathrin binding(GO:0030276) |
0.4 | 3.9 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.4 | 1.2 | GO:0016015 | morphogen activity(GO:0016015) |
0.4 | 1.5 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.4 | 2.7 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.4 | 11.5 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.4 | 1.2 | GO:0034188 | apolipoprotein receptor activity(GO:0030226) apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
0.4 | 9.9 | GO:0030506 | ankyrin binding(GO:0030506) |
0.4 | 0.8 | GO:0001729 | ceramide kinase activity(GO:0001729) |
0.4 | 4.9 | GO:0042731 | PH domain binding(GO:0042731) |
0.4 | 0.4 | GO:0005330 | dopamine:sodium symporter activity(GO:0005330) |
0.4 | 9.4 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.4 | 3.0 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.4 | 46.0 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.4 | 0.7 | GO:0051425 | PTB domain binding(GO:0051425) |
0.4 | 7.7 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.4 | 2.2 | GO:0052723 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.4 | 2.9 | GO:0004084 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.4 | 3.3 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.4 | 8.0 | GO:0032183 | SUMO binding(GO:0032183) |
0.4 | 6.5 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.4 | 2.1 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.4 | 1.4 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
0.4 | 3.2 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.3 | 1.0 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
0.3 | 5.9 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.3 | 2.8 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.3 | 11.0 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.3 | 3.1 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.3 | 1.0 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
0.3 | 1.4 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.3 | 11.7 | GO:0030546 | receptor activator activity(GO:0030546) |
0.3 | 2.1 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.3 | 6.2 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.3 | 1.0 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.3 | 135.5 | GO:0015631 | tubulin binding(GO:0015631) |
0.3 | 1.7 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.3 | 5.3 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.3 | 4.6 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.3 | 1.3 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.3 | 0.7 | GO:1990269 | RNA polymerase II C-terminal domain phosphoserine binding(GO:1990269) |
0.3 | 1.6 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.3 | 6.6 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.3 | 1.2 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.3 | 0.9 | GO:0061769 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
0.3 | 15.4 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.3 | 1.2 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.3 | 9.2 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.3 | 1.5 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.3 | 1.5 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
0.3 | 0.9 | GO:0022839 | ion gated channel activity(GO:0022839) |
0.3 | 1.8 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.3 | 1.5 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.3 | 1.8 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.3 | 0.9 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.3 | 11.4 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.3 | 0.9 | GO:0070401 | NADP+ binding(GO:0070401) |
0.3 | 0.9 | GO:0032129 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
0.3 | 1.2 | GO:0045183 | translation factor activity, non-nucleic acid binding(GO:0045183) |
0.3 | 2.3 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.3 | 0.3 | GO:0001083 | transcription factor activity, RNA polymerase II basal transcription factor binding(GO:0001083) |
0.3 | 2.0 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.3 | 0.6 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.3 | 0.8 | GO:0001888 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
0.3 | 1.4 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.3 | 0.6 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
0.3 | 0.8 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.3 | 11.6 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.3 | 1.1 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.3 | 1.9 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.3 | 1.9 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.3 | 2.2 | GO:0031432 | titin binding(GO:0031432) |
0.3 | 3.0 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.3 | 1.6 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.3 | 0.8 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.3 | 4.8 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.3 | 0.8 | GO:0000700 | mismatch base pair DNA N-glycosylase activity(GO:0000700) |
0.3 | 1.6 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.3 | 0.8 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.3 | 1.9 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
0.3 | 13.8 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.3 | 5.8 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.3 | 0.8 | GO:0030955 | potassium ion binding(GO:0030955) |
0.3 | 0.8 | GO:0001147 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
0.3 | 0.8 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.3 | 1.6 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.3 | 2.1 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.3 | 2.3 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.3 | 2.6 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.3 | 5.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.3 | 2.8 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.2 | 2.5 | GO:0016247 | channel regulator activity(GO:0016247) |
0.2 | 1.5 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.2 | 40.4 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.2 | 5.0 | GO:0019956 | chemokine binding(GO:0019956) |
0.2 | 7.7 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.2 | 7.9 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.2 | 1.4 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.2 | 1.2 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.2 | 0.7 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.2 | 0.9 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.2 | 6.6 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.2 | 7.9 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.2 | 1.4 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.2 | 2.6 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.2 | 0.5 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.2 | 0.7 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.2 | 4.3 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.2 | 4.6 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.2 | 6.8 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.2 | 3.1 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.2 | 1.6 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.2 | 0.9 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
0.2 | 0.7 | GO:0015292 | uniporter activity(GO:0015292) |
0.2 | 1.7 | GO:0042285 | xylosyltransferase activity(GO:0042285) |
0.2 | 3.5 | GO:0031005 | filamin binding(GO:0031005) |
0.2 | 5.4 | GO:0017022 | myosin binding(GO:0017022) |
0.2 | 0.4 | GO:0004921 | interleukin-11 receptor activity(GO:0004921) interleukin-11 binding(GO:0019970) |
0.2 | 3.4 | GO:1905030 | voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.2 | 3.0 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.2 | 2.1 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.2 | 0.6 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.2 | 1.9 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.2 | 5.5 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.2 | 0.4 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.2 | 0.6 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.2 | 1.9 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.2 | 4.8 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.2 | 3.1 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.2 | 1.2 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.2 | 1.9 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.2 | 1.0 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.2 | 1.2 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.2 | 0.8 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.2 | 0.6 | GO:0004133 | glycogen debranching enzyme activity(GO:0004133) 4-alpha-glucanotransferase activity(GO:0004134) amylo-alpha-1,6-glucosidase activity(GO:0004135) |
0.2 | 1.2 | GO:0043398 | HLH domain binding(GO:0043398) SUMO conjugating enzyme activity(GO:0061656) |
0.2 | 2.1 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.2 | 6.4 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.2 | 11.2 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.2 | 4.0 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.2 | 0.6 | GO:0008160 | protein tyrosine phosphatase activator activity(GO:0008160) |
0.2 | 0.6 | GO:0005174 | CD40 receptor binding(GO:0005174) |
0.2 | 0.7 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.2 | 1.1 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.2 | 1.3 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.2 | 19.0 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.2 | 0.7 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
0.2 | 14.7 | GO:0002039 | p53 binding(GO:0002039) |
0.2 | 0.5 | GO:0042610 | CD8 receptor binding(GO:0042610) |
0.2 | 3.9 | GO:0019905 | syntaxin binding(GO:0019905) |
0.2 | 1.4 | GO:0051400 | BH domain binding(GO:0051400) |
0.2 | 0.5 | GO:0052596 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
0.2 | 10.2 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.2 | 0.3 | GO:0030298 | receptor signaling protein tyrosine kinase activator activity(GO:0030298) |
0.2 | 1.0 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
0.2 | 0.8 | GO:0070287 | ferritin receptor activity(GO:0070287) |
0.2 | 3.5 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.2 | 2.1 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.2 | 2.0 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.2 | 1.1 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.2 | 2.2 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.2 | 0.6 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.2 | 0.8 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.2 | 1.7 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.2 | 0.6 | GO:0001032 | RNA polymerase III type 3 promoter DNA binding(GO:0001032) |
0.2 | 0.8 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.2 | 4.4 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.2 | 1.5 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.2 | 0.6 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.2 | 0.9 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.2 | 0.2 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.1 | 4.5 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.1 | 1.0 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 0.7 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 0.4 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.1 | 1.0 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.1 | 0.9 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.1 | 0.8 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.1 | 2.0 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 1.3 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.1 | 0.7 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 3.7 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 3.3 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 1.1 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 38.6 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 0.5 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.1 | 0.3 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.1 | 2.3 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 0.5 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
0.1 | 0.9 | GO:0051861 | glycolipid binding(GO:0051861) |
0.1 | 0.5 | GO:0035240 | dopamine binding(GO:0035240) |
0.1 | 0.5 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.1 | 36.1 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 0.5 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.1 | 0.5 | GO:0001003 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) |
0.1 | 1.8 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 1.1 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 0.5 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.1 | 0.6 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 0.5 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
0.1 | 0.3 | GO:0052744 | phosphatidylinositol monophosphate phosphatase activity(GO:0052744) |
0.1 | 0.3 | GO:0030622 | U4atac snRNA binding(GO:0030622) |
0.1 | 0.2 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 1.2 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 1.0 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.1 | 1.1 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 3.6 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.2 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.1 | 0.7 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 0.8 | GO:0000150 | recombinase activity(GO:0000150) |
0.1 | 0.3 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.1 | 1.1 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 1.8 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 0.3 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.1 | 2.3 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.3 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.1 | 3.4 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.1 | 0.3 | GO:0019107 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
0.1 | 0.6 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
0.1 | 0.3 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
0.1 | 1.0 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 0.3 | GO:0004798 | thymidylate kinase activity(GO:0004798) |
0.1 | 0.4 | GO:0008169 | C-methyltransferase activity(GO:0008169) |
0.1 | 0.5 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.5 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.1 | 0.3 | GO:0003896 | DNA primase activity(GO:0003896) |
0.1 | 0.5 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.1 | 0.6 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 0.6 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.1 | 0.3 | GO:0047291 | lactosylceramide alpha-2,3-sialyltransferase activity(GO:0047291) |
0.1 | 0.3 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
0.1 | 0.7 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) |
0.1 | 0.3 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 0.8 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.1 | 0.4 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 1.8 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.3 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.1 | 0.3 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.1 | 0.5 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 0.2 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.1 | 0.7 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 1.6 | GO:0030371 | translation repressor activity(GO:0030371) |
0.1 | 2.9 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.1 | 0.2 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.1 | 0.3 | GO:0036122 | BMP binding(GO:0036122) |
0.1 | 0.4 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.1 | 0.3 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 2.6 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.1 | 0.7 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.9 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.3 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.1 | 0.3 | GO:0016499 | orexin receptor activity(GO:0016499) |
0.1 | 0.5 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 0.3 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 0.5 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.1 | 0.3 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.1 | 0.3 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.1 | 0.6 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.1 | 0.6 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 29.3 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.1 | 1.2 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.1 | 0.4 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.1 | 0.6 | GO:0004875 | complement receptor activity(GO:0004875) |
0.1 | 0.5 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.1 | 36.3 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.1 | 1.8 | GO:0042805 | actinin binding(GO:0042805) |
0.1 | 0.1 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.1 | 0.7 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 0.2 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 0.2 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.1 | 1.0 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.1 | 0.6 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 0.3 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.1 | 0.2 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
0.1 | 0.5 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.1 | 0.2 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.1 | 0.5 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.1 | 3.7 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.1 | 0.3 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.1 | 0.1 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.1 | 26.5 | GO:0005509 | calcium ion binding(GO:0005509) |
0.1 | 0.4 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.1 | 1.4 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.1 | 0.2 | GO:0019978 | interleukin-3 receptor activity(GO:0004912) interleukin-3 binding(GO:0019978) |
0.0 | 0.2 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.0 | 0.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.1 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.0 | 0.2 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.0 | 0.8 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.0 | 1.0 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.0 | 0.4 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.3 | GO:0015616 | DNA translocase activity(GO:0015616) |
0.0 | 0.6 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.1 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
0.0 | 0.6 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.2 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.5 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.0 | 0.2 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.0 | 0.4 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.0 | 0.1 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.0 | 0.1 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
0.0 | 0.3 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.0 | 0.8 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.1 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.0 | 0.3 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 0.1 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.0 | 0.1 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.0 | 0.2 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.2 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.6 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.0 | 0.2 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.0 | 0.1 | GO:0018271 | biotin-[acetyl-CoA-carboxylase] ligase activity(GO:0004077) biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity(GO:0004078) biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity(GO:0004079) biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity(GO:0004080) biotin-protein ligase activity(GO:0018271) |
0.0 | 0.1 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
0.0 | 0.4 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.0 | 0.3 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.0 | 1.7 | GO:0051117 | ATPase binding(GO:0051117) |
0.0 | 0.4 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.0 | 0.1 | GO:0033883 | pyridoxal phosphatase activity(GO:0033883) |
0.0 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 1.2 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 0.1 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.0 | 0.3 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.0 | GO:0030545 | receptor regulator activity(GO:0030545) |
0.0 | 0.1 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.0 | 0.0 | GO:0032356 | oxidized DNA binding(GO:0032356) |
0.0 | 0.1 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.0 | 0.1 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.0 | 1.5 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.0 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 0.0 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.0 | 0.0 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.0 | 0.1 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.0 | 0.9 | GO:0031267 | small GTPase binding(GO:0031267) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 4.6 | PID S1P S1P1 PATHWAY | S1P1 pathway |
1.0 | 4.0 | ST G ALPHA I PATHWAY | G alpha i Pathway |
1.0 | 20.1 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.9 | 36.9 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.8 | 1.7 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.8 | 13.8 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.8 | 1.5 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.7 | 48.5 | PID REELIN PATHWAY | Reelin signaling pathway |
0.7 | 14.6 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.7 | 29.9 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.7 | 11.4 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.7 | 36.9 | PID RAS PATHWAY | Regulation of Ras family activation |
0.6 | 8.8 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.6 | 13.2 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.6 | 28.0 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.6 | 12.4 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.6 | 26.2 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.6 | 12.2 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.6 | 39.7 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.5 | 16.6 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.5 | 16.0 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.5 | 6.0 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.5 | 15.6 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.5 | 12.1 | PID CDC42 PATHWAY | CDC42 signaling events |
0.5 | 11.1 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.5 | 2.4 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.5 | 94.1 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.5 | 36.3 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.5 | 2.3 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.4 | 3.0 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.4 | 2.8 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.4 | 23.3 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.4 | 9.7 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.4 | 5.0 | PID ARF6 PATHWAY | Arf6 signaling events |
0.4 | 7.7 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.4 | 13.6 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.4 | 4.0 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.3 | 0.7 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.3 | 5.3 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.3 | 7.6 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.3 | 4.9 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.3 | 11.5 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.3 | 6.9 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.3 | 8.5 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.3 | 4.7 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.3 | 1.2 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.3 | 4.6 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.3 | 0.3 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.3 | 14.8 | PID LKB1 PATHWAY | LKB1 signaling events |
0.3 | 7.7 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.3 | 10.0 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.3 | 1.3 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.3 | 8.9 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.3 | 9.3 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.3 | 1.0 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.2 | 0.5 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.2 | 4.1 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.2 | 1.4 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.2 | 9.1 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.2 | 5.0 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.2 | 0.9 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.2 | 5.2 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.2 | 23.7 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.2 | 6.3 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.2 | 10.4 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.2 | 12.7 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.2 | 0.8 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.2 | 1.5 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.2 | 5.4 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.2 | 2.4 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.2 | 1.2 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.2 | 1.3 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.2 | 2.3 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.2 | 1.1 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.2 | 5.4 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 2.9 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 2.4 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 2.9 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 4.1 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 3.8 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 0.2 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 1.7 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 0.7 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 6.1 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 0.5 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 5.0 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 2.0 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 1.4 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 0.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 4.6 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 3.5 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 1.9 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 1.8 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.1 | 14.7 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 0.7 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 0.7 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 1.1 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 4.6 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 18.3 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 21.9 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.1 | 0.5 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 0.7 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 0.1 | ST ADRENERGIC | Adrenergic Pathway |
0.0 | 0.6 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 3.8 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.3 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 0.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.6 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 1.0 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.2 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.1 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 0.6 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.4 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 0.9 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.3 | PID ATM PATHWAY | ATM pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 43.6 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
1.7 | 41.7 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
1.6 | 22.5 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
1.3 | 1.3 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
1.2 | 32.1 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
1.2 | 25.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
1.1 | 58.0 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
1.1 | 68.7 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
1.1 | 14.9 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
1.1 | 21.1 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
1.0 | 14.5 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
1.0 | 16.1 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
1.0 | 6.8 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
1.0 | 22.1 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.9 | 45.6 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.9 | 56.8 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.9 | 51.2 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.8 | 3.3 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.8 | 15.7 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.8 | 43.9 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.8 | 37.6 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.8 | 1.5 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.7 | 2.2 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.7 | 7.5 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.7 | 3.4 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.7 | 13.7 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.6 | 15.5 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.6 | 9.5 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.6 | 9.5 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.6 | 20.0 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.6 | 10.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.6 | 3.9 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.5 | 9.0 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.5 | 15.4 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.5 | 1.0 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.5 | 16.0 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.5 | 3.2 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.5 | 40.4 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.4 | 5.3 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.4 | 9.3 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.4 | 1.3 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.4 | 16.4 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.4 | 21.7 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.4 | 4.4 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.4 | 0.8 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.4 | 2.7 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.4 | 2.2 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.4 | 1.1 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.4 | 7.0 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.3 | 3.1 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.3 | 4.3 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.3 | 10.6 | REACTOME KINESINS | Genes involved in Kinesins |
0.3 | 1.3 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.3 | 8.1 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.3 | 0.6 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.3 | 8.7 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.3 | 11.6 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.3 | 1.2 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
0.3 | 12.8 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.3 | 4.9 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.3 | 6.4 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.3 | 3.7 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.3 | 7.1 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.3 | 7.1 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.3 | 0.5 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |
0.3 | 21.6 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.3 | 9.7 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.3 | 7.6 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.2 | 5.4 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.2 | 1.0 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.2 | 1.7 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.2 | 0.7 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.2 | 1.2 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.2 | 6.3 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.2 | 1.8 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.2 | 8.0 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.2 | 3.9 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.2 | 1.7 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.2 | 10.5 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.2 | 7.1 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.2 | 1.0 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.2 | 11.0 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.2 | 1.4 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.2 | 4.9 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.2 | 5.2 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.2 | 3.2 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.2 | 5.5 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.2 | 4.4 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.2 | 1.5 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.2 | 2.0 | REACTOME OPSINS | Genes involved in Opsins |
0.2 | 3.2 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.2 | 0.2 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.2 | 2.2 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.2 | 4.2 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.2 | 0.3 | REACTOME SIGNALING BY NOTCH | Genes involved in Signaling by NOTCH |
0.2 | 2.3 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.2 | 2.3 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 9.3 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.2 | 20.5 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.2 | 7.1 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.2 | 3.8 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.1 | 5.1 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 0.7 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.1 | 2.3 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 1.3 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.1 | 2.9 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 15.4 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 1.6 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.1 | 1.1 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 3.4 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 0.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 3.1 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 4.7 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 0.1 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.1 | 11.6 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 2.0 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.1 | 4.5 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.1 | 1.7 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 1.8 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 1.9 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 0.6 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
0.1 | 22.7 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 6.8 | REACTOME NEURONAL SYSTEM | Genes involved in Neuronal System |
0.1 | 0.9 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 0.6 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 0.7 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
0.1 | 6.4 | REACTOME SIGNALING BY GPCR | Genes involved in Signaling by GPCR |
0.1 | 2.2 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.1 | 0.4 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.1 | 0.2 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 0.4 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 0.8 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 0.5 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.0 | 0.1 | REACTOME BASE EXCISION REPAIR | Genes involved in Base Excision Repair |
0.0 | 0.5 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.0 | 0.2 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.0 | 0.2 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 0.6 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.1 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.0 | 0.6 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.5 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 1.2 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.2 | REACTOME EARLY PHASE OF HIV LIFE CYCLE | Genes involved in Early Phase of HIV Life Cycle |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.0 | 0.5 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.0 | 0.5 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |